Document:

EXHIBIT
      10.23 

    
      

      

    

     

     

    REGISTRATION
      RIGHTS AGREEMENT

     

    Dated
      as of June 8, 2007

     

    Among

     

    Energy
      XXI Gulf Coast, Inc., 

    as
      Issuer,

     

    The
      Guarantors 

    listed
      on the signature pages hereto,

     

    Jefferies
      & Company, Inc., Greenwich Capital Markets, Inc., BNP Paribas Securities

    Corp.,
      BMO Capital Markets Corp., Capital One Southcoast, Inc. and Natexis

    Bleichroeder
      Inc. 

    as
      Initial Purchasers 

     

    and

     

    the
      Purchasers listed on the signature page hereto

     

    $750,000,000
      aggregate principal amount of 10% Senior Notes due 2013

     

     

    
      

      

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    
      TABLE
        OF CONTENTS

    

     

    
      
        	 	 	 	 	 	 	Page	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  1.

              	 	 	
                DEFINITIONS

              	 	 	
                1

              	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  2.

              	 	 	
                EXCHANGE
                  OFFER

              	 	 	
                5

              	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  3.

              	 	 	
                SHELF
                  REGISTRATION

              	 	 	
                8

              	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  4.

              	 	 	
                LIQUIDATED
                  DAMAGES

              	 	 	
                9

              	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  5.

              	 	 	
                REGISTRATION
                  PROCEDURES

              	 	 	
                11

              	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  6.

              	 	 	
                REGISTRATION
                  EXPENSES

              	 	 	
                18

              	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  7.

              	 	 	
                INDEMNIFICATION

              	 	 	
                19

              	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  8.

              	 	 	
                RULES
                  144 AND 144A

              	 	 	
                22

              	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  9.

              	 	 	
                UNDERWRITTEN
                  REGISTRATIONS

              	 	 	
                22

              	 
	 	 	 	 	 	 	 	 
	
                SECTION
                  10.

              	 	 	
                MISCELLANEOUS

              	 	 	
                23

              	 

      

       

      
        
          
          

        

        
          i

          
            

          

        

        
          
          

        

      

       

    

    REGISTRATION
      RIGHTS AGREEMENT

     

    This
      Registration Rights Agreement, dated as of June 8, 2007 (this "Agreement"),
      is
      entered into among Energy XXI Gulf Coast, Inc., a Delaware corporation (the
      "Company"),
      the
      guarantors listed on the signature pages hereto (the "Guarantors"),
      Jefferies & Company, Inc., Greenwich Capital Markets, Inc., BNP Paribas
      Securities Corp., BMO Capital Markets Corp., Capital One Southcoast, Inc. and
      Natexis Bleichroeder Inc., as initial purchasers (the "Initial
      Purchasers")
      and
      the purchasers listed on the signature page hereto (the "Purchasers").

     

    This
      Agreement is entered into in connection with the Regulation S Purchase
      Agreement, dated as of May 24, 2007, among the Company, the Guarantors and
      the
      Initial Purchasers (the "Regulation
      S Purchase
      Agreement")
      and
      the Regulation D Note Purchase Agreement, dated as of __, 2007, among the
      Company, the Guarantors and the Purchasers (the "Regulation D
      Purchase Agreement,"
      and
      together with the Regulation S Purchase Agreement, the "Purchase
      Agreements")
      pursuant to which the Company issued and sold (i) outside the United States
      $__ in aggregate principal amount of the Company's 10% Notes due 2013 (the
      "Regulation
      S Notes"
      to the
      Initial Purchasers in a transaction exempt from the registration requirements
      of
      the Securities Act (the "Regulation
      S Offering")
      in
      reliance upon Regulation S promulgated under the Securities Act of 1933, as
      amended, and the rules and regulations of the Securities and Exchange Commission
      (the "Commission")
      thereunder (collectively, the "Securities
      Act")
      pursuant to the Regulation S Purchase Agreement and (ii) in the United
      States $__ in aggregate principal amount of the Company's 10% Notes due 2013
      (the
      "Regulation
      D Notes"
      and
      together with the Regulation S Notes, the "Notes")
      to the
      Purchasers in a private placement (the "Regulation
      D Placement")
      without being registered under the Securities Act in reliance upon Section
      4(2)
      thereof and/or Regulation D thereunder pursuant to the Regulation D Purchase
      Agreement. The execution and delivery of this Agreement is a condition to the
      Initial Purchasers' obligation to purchase the Regulation S Notes under the
      Regulation S Purchase Agreement and the Purchasers' obligation to purchase
      the
      Regulation D Notes under the Regulation D Purchase
      Agreement.

     

    The
      parties hereby agree as follows:

     

    Section
      1.  Definitions.

     

    As
      used
      in this Agreement, the following terms shall have the following
      meanings:

     

    "Action"
      shall
      have the meaning set forth in Section 7(c) hereof.

     

    "Advice"
      shall
      have the meaning set forth in Section 5 hereof.

     

    "Agreement"
      shall
      have the meaning set forth in the first introductory paragraph
      hereto.

     

    "Applicable
      Period"
      shall
      have the meaning set forth in Section 2(b) hereof.

     

    "Board
      of Directors"
      shall
      have the meaning set forth in Section 5 hereof.

     

    "Business
      Day"
      shall
      mean a day that is not a Legal Holiday.

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

     

    "Commission"
      shall
      have the meaning set forth in the preamble hereof.

     

    "Day"
      shall
      mean a calendar day.

     

    "Damages
      Payment Date"
      shall
      have the meaning set forth in Section 4(b) hereof.

     

    "Delay
      Period"
      shall
      have the meaning set forth in Section 5 hereof.

     

    "Effectiveness
      Period"
      shall
      have the meaning set forth in Section 3(b) hereof.

     

    "Exchange
      Act"
      shall
      mean the Securities Exchange Act of 1934, as amended, and the rules and
      regulations of the Commission promulgated thereunder.

     

    "Exchange
      Notes"
      shall
      have the meaning set forth in Section 2(a) hereof.

     

    "Exchange
      Offer"
      shall
      have the meaning set forth in Section 2(a) hereof.

     

    "Exchange
      Offer Registration Statement"
      shall
      have the meaning set forth in Section 2(a) hereof.

     

    "Filing
      Date"
      shall
      have the meaning set forth in Section 3(a) hereof.

     

    "Holder"
      shall
      mean any holder of a Registrable Note or Registrable Notes.

     

    "Indenture"
      shall
      mean the Indenture, dated as of June 8, 2007, among the Company, the Guarantors
      and Wells Fargo Bank, National Association, as trustee, pursuant to which the
      Notes are being issued, as amended or supplemented from time to time in
      accordance with the terms thereof.

     

    "Initial
      Purchasers" shall
      have the meaning set forth in the preamble hereof.

     

    "Inspectors"
      shall
      have the meaning set forth in Section 5(n) hereof.

     

    "Issue
      Date"
      shall
      mean June 8, 2007, the date of original issuance of the Notes.

     

    "Issuer"
      shall
      mean the Company and the Guarantors, such that the obligations of the Company
      and the Guarantors under this Agreement shall be joint and several obligations
      in every respect including but not limited to the obligations to pay any
      Liquidated Damages, other amounts and any indemnification and contribution
      obligations, in each case, as set forth in this Agreement, and shall also
      include such parties' permitted successors and assigns.

     

    "Legal
      Holiday"
      shall
      mean a Saturday, a Sunday or a day on which banking institutions in New York,
      New York are required by law, regulation or executive order to remain
      closed.

     

    "Liquidated
      Damages"
      shall
      have the meaning set forth in Section 4(a) hereof.

     

    "Losses"
      shall
      have the meaning set forth in Section 7(a) hereof.

     

    "NASD"
      shall
      have the meaning set forth in Section 5(s) hereof.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    "Notes"
      shall
      have the meaning set forth in the second introductory paragraph
      hereto.

     

    "Participant"
      shall
      have the meaning set forth in Section 7(a) hereof.

     

    "Participating
      Broker-Dealer"
      shall
      have the meaning set forth in Section 2(b) hereof.

     

    "Person"
      shall
      mean an individual, corporation, partnership, joint venture association, joint
      stock company, trust, unincorporated limited liability company, government
      or
      any agency or political subdivision thereof or any other entity.

     

    "Private
      Exchange"
      shall
      have the meaning set forth in Section 2(b) hereof.

     

    "Private
      Exchange Notes"
      shall
      have the meaning set forth in Section 2(b) hereof.

     

    "Prospectus"
      shall
      mean the prospectus included in any Registration Statement (including, without
      limitation, any prospectus subject to completion and a prospectus that includes
      any information previously omitted from a prospectus filed as part of an
      effective registration statement in reliance upon Rule 430A promulgated under
      the Securities Act), as amended or supplemented by any prospectus supplement,
      and all other amendments and supplements to the Prospectus, including
      post-effective amendments, and all material incorporated by reference or deemed
      to be incorporated by reference in such Prospectus. 

     

    "Purchasers"
      shall
      have the meaning set forth in the preamble hereof.

     

    "Records"
      shall
      have the meaning set forth in Section 5(n) hereof.

     

    "Registrable
      Notes"
      shall
      mean each Note upon its original issuance and at all times subsequent thereto,
      each Exchange Note as to which Section 2(c)(iv) hereof is applicable upon
      original issuance and at all times subsequent thereto and each Private Exchange
      Note upon original issuance thereof and at all times subsequent thereto, in
      each
      case until (i) a Registration Statement (other than, with respect to any
      Exchange Note as to which Section 2(c)(iv) hereof is applicable, the Exchange
      Offer Registration Statement) covering such Note, Exchange Note or Private
      Exchange Note has been declared effective by the Commission and such Note,
      Exchange Note or such Private Exchange Note, as the case may be, has been
      disposed of in accordance with such effective Registration Statement,
      (ii) such Note has been exchanged pursuant to the Exchange Offer for an
      Exchange Note or Exchange Notes that may be resold without restriction under
      state and federal securities laws, (iii) such Note, Exchange Note or
      Private Exchange Note, as the case may be, ceases to be outstanding or (iv)
      such
      Note, Exchange Note or Private Exchange Note has been sold in compliance with
      Rule 144 or is salable pursuant to Rule 144(k) (or any similar
      provision then in force other than Rule 144A).

     

    "Registration
      Default"
      shall
      have the meaning set forth in Section 4(a) hereof.

     

    "Registration
      Statement"
      shall
      mean any appropriate registration statement of the Issuer covering any of the
      Registrable Notes filed with the Commission under the Securities Act, and all
      amendments and supplements to any such Registration Statement, including
      post-effective amendments, in each case including the Prospectus contained
      therein, all exhibits thereto and all material incorporated by reference
      therein.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    "Regulation
      D Notes"
      shall
      have the meaning set forth in the preamble hereof.

     

    "Regulation
      D Placement" shall
      have the meaning set forth in the preamble hereof.

     

    "Regulation
      D Purchase
      Agreement"
      shall
      have the meaning set forth in the preamble hereof.

     

    "Regulation
      D Registration Rights Agreement"
      shall
      have the meaning set forth in the preamble hereof

     

    "Regulation
      S Notes"
      shall
      have the meaning set forth in the preamble hereof.

     

    "Regulation
      S Offering"
      shall
      have the meaning set forth in the preamble hereof.

     

    "Regulation
      S Purchase Agreement"
      shall
      have the meaning set forth in the preamble hereof.

     

    "Requesting
      Participating Broker-Dealer"
      shall
      have the meaning set forth in Section 2(b) hereof.

     

    "Rule
      144"
      shall
      mean Rule 144 promulgated under the Securities Act, as such Rule may be amended
      from time to time, or any similar rule (other than Rule 144A) or regulation
      hereafter adopted by the Commission providing for offers and sales of securities
      made in compliance therewith resulting in offers and sales by subsequent holders
      that are not affiliates of an issuer of such securities being free of the
      registration and prospectus delivery requirements of the Securities
      Act.

     

    "Rule
      144A"
      shall
      mean Rule 144A promulgated under the Securities Act, as such Rule may be amended
      from time to time, or any similar rule (other than Rule 144) or regulation
      hereafter adopted by the Commission.

     

    "Rule
      415"
      shall
      mean Rule 415 promulgated under the Securities Act, as such Rule may be amended
      from time to time, or any similar rule or regulation hereafter adopted by the
      Commission.

     

    "Securities
      Act"
      shall
      have the meaning set forth in the preamble hereof.

     

    "Shelf
      Filing Event"
      shall
      have the meaning set forth in Section 2(c) hereof.

     

    "Shelf
      Registration"
      shall
      have the meaning set forth in Section 3(a) hereof.

     

    "Shelf
      Registration Statement"
      shall
      mean a Registration Statement filed in connection with a Shelf
      Registration.

     

    "TIA"
      shall
      mean the Trust Indenture Act of 1939, as amended.

     

    "Trustee"
      shall
      mean the trustee under the Indenture and the trustee (if any) under any
      indenture governing the Exchange Notes and Private Exchange Notes.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    "Underwritten
      registration or underwritten offering"
      shall
      mean a registration in which securities of the Issuer are sold to an underwriter
      for reoffering to the public.

     

    Section
      2.  Exchange
      Offer.

     

    (a)  To
      the
      extent not prohibited by any applicable law or applicable interpretation of
      the
      Commission, the Issuer shall (i) file within 90 days of the Issue Date a
      Registration Statement (the "Exchange
      Offer Registration Statement")
      with
      the Commission on an appropriate registration form with respect to a registered
      offer (the "Exchange
      Offer")
      to
      exchange any and all of the Registrable Notes for a like aggregate principal
      amount of notes (the "Exchange
      Notes")
      that
      are identical in all material respects to the Notes (except that the Exchange
      Notes shall not contain terms with respect to transfer restrictions or
      Liquidated Damages upon a Registration Default) and (ii) use its reasonable
      best
      efforts to cause the Exchange Offer Registration Statement to be declared
      effective under the Securities Act within 270 days after the Issue Date. Upon
      the Exchange Offer Registration Statement being declared effective by the
      Commission, the Issuer will: (i) use its reasonable best efforts to commence
      the
      Exchange Offer as soon as practicable after the Exchange Offer Registration
      Statement is declared effective, (ii) keep the Exchange Offer open for not
      less
      than 30 days (or longer if required by applicable law) after the date notice
      of
      the Exchange Offer is mailed to Holders, and (iii) use its reasonable best
      efforts to consummate the Exchange Offer within 40 days after the date on which
      the Exchange Offer Registration Statement is declared effective. 

     

    Each
      Holder that participates in the Exchange Offer will be required to represent
      to
      the Issuer in writing that (i) any Exchange Notes to be received by it will
      be
      acquired in the ordinary course of its business, (ii) it has no arrangement
      or
      understanding with any Person to participate in the distribution (within the
      meaning of the Securities Act) of the Exchange Notes in violation of the
      provisions of the Securities Act or, if it is an affiliate, it will comply
      with
      the registration and prospectus delivery requirements of the Securities Act
      to
      the extent applicable, (iii) if such Holder is not a broker-dealer, it is not
      engaged in, and does not intend to engage in, a distribution of Exchange Notes,
      (iv) if such Holder is a broker-dealer that will receive Exchange Notes for
      its
      own account in exchange for Notes that were acquired as a result of
      market-making or other trading activities, it will comply with the applicable
      provisions of the Securities Act in connection with any resale of such Exchange
      Notes, (v) such Holder has full power and authority to transfer the Notes
      in exchange for the Exchange Notes and that the Issuer will acquire good and
      unencumbered title thereto free and clear of any liens, restrictions, charges
      or
      encumbrances and not subject to any adverse claims; and (vi) such Holder is
      not
      an "affiliate" (as defined in Rule 405 promulgated under the Securities Act)
      of
      the Issuer.

     

    (b)  The
      Issuer, the Purchasers and the Initial Purchasers acknowledge that the staff
      of
      the Commission has taken the position that any broker-dealer that elects to
      exchange Notes that were acquired by such broker-dealer for its own account
      as a
      result of market-making or other trading activities for Exchange Notes in the
      Exchange Offer (a "Participating
      Broker-Dealer")
      may be
      deemed to be an "underwriter" within the meaning of the Securities Act and
      must
      deliver a prospectus meeting the requirements of the Securities Act in
      connection with any resale of such Exchange Notes (other than a resale of an
      unsold allotment resulting from the original offering of the Regulation S
      Notes).

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    The
      Issuer, the Purchasers and the Initial Purchasers also acknowledge that the
      staff of the Commission has taken the position that if the Prospectus contained
      in the Exchange Offer Registration Statement includes a plan of distribution
      containing a statement to the above effect and the means by which Participating
      Broker-Dealers may resell the Exchange Notes, without naming the Participating
      Broker-Dealers or specifying the amount of Exchange Notes owned by them, such
      Prospectus may be delivered by Participating Broker-Dealers to satisfy their
      prospectus delivery obligations under the Securities Act in connection with
      resales of Exchange Notes for their own accounts, so long as the Prospectus
      otherwise meets the requirements of the Securities Act.

     

    In
      light
      of the foregoing, if requested by a Participating Broker-Dealer (a "Requesting
      Participating Broker-Dealer"),
      the
      Issuer agrees to use its reasonable best efforts to keep the Exchange Offer
      Registration Statement continuously effective for a period not to exceed 120
      days after the date on which the Exchange Registration Statement is declared
      effective, or such longer period if extended pursuant to the last paragraph
      of
      Section 5 hereof (such period, the "Applicable
      Period"),
      or
      such earlier date as all Requesting Participating Broker-Dealers shall have
      notified the Issuer in writing that such Requesting Participating Broker-Dealers
      have resold all Exchange Notes acquired in the Exchange Offer. The Issuer shall
      include a plan of distribution in such Exchange Offer Registration Statement
      that meets the requirements set forth in the preceding paragraph.

     

    If,
      prior
      to consummation of the Exchange Offer, the Initial Purchaser or any Holder,
      as
      the case may be, holds any Regulation S Notes acquired by it that have, or
      that
      are reasonably likely to be determined to have, the status of an unsold
      allotment in an initial distribution, or any Holder is not entitled to
      participate in the Exchange Offer, the Issuer upon the request of the Initial
      Purchaser or any such Holder, as the case may be, shall simultaneously with
      the
      delivery of the Exchange Notes in the Exchange Offer, issue and deliver to
      the
      Initial Purchasers or any such Holder, as the case may be, in exchange (the
      "Private
      Exchange")
      for
      such Notes held by the Initial Purchasers or any such Holder, as the case may
      be, a like principal amount of notes (the "Private
      Exchange Notes")
      of the
      Issuer that are identical in all material respects to the Exchange Notes except
      that the Private Exchange Notes may be subject to restrictions on transfer
      and
      bear a legend to such effect. The Private Exchange Notes shall be issued
      pursuant to the same indenture as the Exchange Notes and bear the same CUSIP
      number as the corresponding Exchange Notes.

     

    For
      each
      Note surrendered in the Exchange Offer, the Holder will receive an Exchange
      Note
      having a principal amount equal to that of the surrendered Note. Interest on
      each Exchange Note and Private Exchange Note issued pursuant to the Exchange
      Offer and in the Private Exchange will accrue from the last interest payment
      date on which interest was paid on the Notes surrendered in exchange therefor
      or, if no interest has been paid on the Notes, from the Issue Date.

     

    Upon
      consummation of the Exchange Offer in accordance with this Section 2, the Issuer
      shall have no further registration obligations other than the Issuer's
      continuing registration obligations with respect to (i) Private Exchange Notes,
      (ii) Exchange Notes held by Participating Broker-Dealers and (iii) Notes or
      Exchange Notes as to which clause (c)(iii) of this Section 2
      applies.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    In
      connection with the Exchange Offer, the Issuer shall:

     

    (1) mail
      or
      cause to be mailed to each Holder entitled to participate in the Exchange Offer
      a copy of the Prospectus forming part of the Exchange Offer Registration
      Statement, together with an appropriate letter of transmittal and related
      documents;

     

    (2) utilize
      the services of a depositary for the Exchange Offer with an address in the
      Borough of Manhattan, The City of New York; 

     

    (3) permit
      Holders to withdraw tendered Notes at any time prior to the close of business,
      New York time, on the last Business Day on which the Exchange Offer shall remain
      open; and

     

    (4) otherwise
      comply in all material respects with all applicable laws, rules and
      regulations.

     

    As
      soon
      as practicable after the close of the Exchange Offer and the Private Exchange,
      if any, the Issuer shall:

     

    (1) accept
      for exchange all Notes validly tendered and not validly withdrawn by the Holders
      pursuant to the Exchange Offer and the Private Exchange, if any;

     

    (2) deliver
      or cause to be delivered to the Trustee for cancellation all Notes so accepted
      for exchange; and

     

    (3) cause
      the
      Trustee to authenticate and deliver promptly to each such Holder of Notes,
      Exchange Notes or Private Exchange Notes, as the case may be, equal in principal
      amount to the Registrable Notes of such Holder so accepted for
      exchange.

     

    The
      Exchange Offer and the Private Exchange shall not be subject to any conditions,
      other than that (i) the Exchange Offer or Private Exchange, as the case may
      be, does not violate applicable law or any applicable interpretation of the
      staff of the Commission, (ii) no action or proceeding shall have been
      instituted or threatened in any court or by any governmental agency which might
      materially impair the ability of the Issuer to proceed with the Exchange Offer
      or the Private Exchange, and no material adverse development shall have occurred
      in any existing action or proceeding with respect to the Issuer and
      (iii) all governmental approvals shall have been obtained, which approvals
      the Issuer deems necessary for the consummation of the Exchange Offer or Private
      Exchange.

     

    The
      Exchange Notes and the Private Exchange Notes shall be issued under (i) the
      Indenture or (ii) an indenture identical in all material respects to the
      Indenture (in either case, with such changes as are necessary to comply with
      any
      requirements of the Commission to effect or maintain the qualification thereof
      under the TIA) and which, in either case, has been qualified under the TIA
      and
      shall provide that (a) the Exchange Notes shall not be subject to the
      transfer restrictions set forth in the Indenture and (b) the Private
      Exchange Notes shall be subject to the transfer restrictions set forth in the
      Indenture. The Indenture or such indenture shall provide that the Exchange
      Notes, the Private Exchange Notes and the Notes shall vote and consent together
      on all matters as one class and that none of the Exchange Notes, the Private
      Exchange Notes or the Notes will have the right to vote or consent as a separate
      class on any matter.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    (c)  In
      the
      event that: 

     

    (i) any
      changes in law or the applicable interpretations of the staff of the Commission
      do not permit the Issuer to effect the Exchange Offer; 

     

    (ii) for
      any
      reason the Exchange Offer is not consummated within 310 days of the Issue Date;
      

     

    (iii)
      a
      Holder notifies the Company following consummation of the Exchange Offer that
      Notes held by it are not eligible to be exchanged for Exchange Notes in the
      Exchange Offer;

     

    (iv) any
      Holder, other than the Initial Purchasers, is prohibited by law or the
      applicable interpretations of the staff of the Commission from participating
      in
      the Exchange Offer or does not receive Exchange Notes on the date of the
      exchange that may be sold without restriction under state and federal securities
      laws (other than due solely to the status of such holder as an affiliate of
      the
      Issuer within the meaning of the Securities Act); or 

     

    (v)
       the
      Initial Purchaser so requests with respect to Regulation S Notes or
      corresponding Private Exchange Notes that have, or that are reasonably likely
      to
      be determined to have, the status of unsold allotments in an initial
      distribution and such Holder so notifies the Company.

     

    (each
      such event referred to in clauses (i) through (v) of this sentence, a
      "Shelf
      Filing Event"),
      then
      the Issuer shall file a Shelf Registration pursuant to Section 3
      hereof.

     

    Section
      3.  Shelf
      Registration.

     

    If
      at any
      time a Shelf Filing Event shall occur, then:

     

    (a)  The
      Issuer shall file promptly with the Commission a Registration Statement for
      an
      offering to be made on a continuous basis pursuant to Rule 415 covering all
      of
      the Registrable Notes not exchanged in the Exchange Offer, Private Exchange
      Notes and Exchange Notes as to which Section 2(c)(iii) is applicable (the
      "Shelf
      Registration").
      The
      Issuer shall use its reasonable best efforts to file with the Commission the
      Shelf Registration as promptly as practicable but in any event within 30 days
      of
      notice of the Shelf Filing Event (the "Filing
      Date").
      The
      Shelf Registration shall be on Form S-1 or another appropriate form permitting
      registration of such Registrable Notes for resale by Holders in the manner
      or
      manners designated by them (including, without limitation, one or more
      underwritten offerings). The Issuer shall not permit any securities other than
      the Registrable Notes to be included in the Shelf Registration.

     

    (b)  The
      Issuer shall use its reasonable best efforts:

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    (i) in
      the
      case of Section 2(c)(i) above, to cause the Shelf Registration Statement to
      be
      declared effective under the Securities Act on or prior to the 270th
      day
      after the Issue Date; 

     

    (ii) in
      the
      case of Sections 2(c)(ii), (iii) or (iv) above, use its reasonable best efforts
      to cause the Shelf Registration Statement to be declared effective under the
      Securities Act on or prior to the 180th
      day
      after the date on which the Shelf Registration Statement is required to be
      filed; and

     

    (iii) use
      its
      reasonable best efforts to keep the Shelf Registration Statement effective
      until
      the earliest of (A) the time when the Notes covered by the Shelf Registration
      Statement can be sold pursuant to Rule 144 without any information under clause
      (c), (e), (f) and (h) of Rule 144, (B) two years from the Issue Date and (c)
      the
      date on which all Notes registered thereunder are disposed of in accordance
      therewith subject to extension pursuant to the penultimate paragraph of Section
      5 hereof (the "Effectiveness
      Period");
      provided,
      however,
      that
      (i) the Effectiveness Period in respect of the Shelf Registration shall be
      extended to the extent required to permit dealers to comply with the applicable
      prospectus delivery requirements of Rule 174 under the Securities Act and as
      otherwise provided herein and (ii) the Issuer may suspend the effectiveness
      of
      the Shelf Registration Statement by written notice to the Holders solely as
      a
      result of the filing of a post-effective amendment to the Shelf Registration
      Statement to incorporate annual audited financial information with respect
      to
      the Issuer where such post-effective amendment is not yet effective and needs
      to
      be declared effective to permit Holders to use the related Prospectus, provided
      that the Effectiveness Period in respect of the Shelf Registration shall be
      extended by such number of days for which effectiveness is suspended under
      this
      clause (ii).

     

    (c)  Supplements
      and Amendments.
      The
      Issuer agrees to supplement or make amendments to the Shelf Registration
      Statement as and when required by the rules, regulations or instructions
      applicable to the registration form used for such Shelf Registration Statement
      or by the Securities Act or rules and regulations thereunder for shelf
      registration, or if reasonably requested by the Holders of a majority in
      aggregate principal amount of the Registrable Notes covered by such Registration
      Statement or by any underwriter of such Registrable Notes.

     

    Section
      4.  Liquidated
      Damages.

     

    (a)  The
      Issuer, the Initial Purchasers and the Purchaser agree that the Holders will
      suffer damages if the Issuer fails to fulfill its obligations under
      Section 2 or Section 3 hereof and that it would not be feasible to
      ascertain the extent of such damages with precision. Accordingly, the Issuer
      agrees that if:

     

    (i)  the
      Issuers fail to file the Exchange Offer Registration Statement with the
      Commission on or prior to the 90th day after the Issue Date,

     

    (ii)  the
      Exchange Offer Registration Statement is not declared effective on or prior
      to
      the 270th day following the Issue Date or, if that day is not a Business Day,
      the next day that is a Business Day;

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

    (iii)  the
      Exchange Offer is not consummated on or prior to the 40th
      day
      following the date on which the Exchange Offer Registration Statement is
      declared effective; 

     

    (iv)  a
      Shelf
      Registration Statement required to be filed pursuant to Section 2(c)(ii), (iii)
      or (iv) is not filed on or prior to the 90th
      day
      following the Shelf Filing Event, or, if that day is not a Business Day, the
      next day that is a Business Day;

     

    (v)  a
      Shelf
      Registration Statement that is either (x) required to be filed pursuant to
      Section 2(c)(i) is not declared effective by the 270th
      day
      after the Shelf Filing Date (or if such day is not a Business Day, the next
      day
      that is a Business Day), or (y) required to be filed pursuant to Section
      2(c)(ii), (iii) or (iv) is not declared effective by the 90th
      day
      after the Filing Date (or, if such day is not a Business Day, the next day
      that
      is a Business Day) or (z) in the case of (x) or (y) of this clause is declared
      effective by such date but thereafter ceases to be effective or usable, except
      if the Shelf Registration ceases to be effective or usable as specifically
      permitted by the penultimate paragraph of Section 5 hereof; or

     

    (vi)  the
      Shelf
      Registration Statement does not remain continuously effective for the
      Effectiveness Period (save and except for any Delay Periods)

     

    (each
      such event referred to in clauses (i) through (vi) a "Registration
      Default"),
      liquidated damages in the form of additional cash interest ("Liquidated
      Damages")
      will
      accrue on the affected Notes and the affected Exchange Notes, as applicable.
      The
      rate of Liquidated Damages will be 0.25% per annum for the first 90-day period
      immediately following the occurrence of a Registration Default, increasing
      by an
      additional 0.25% per annum with respect to each subsequent 90-day period up
      to a
      maximum amount of additional interest of 1.00% per annum, from and including
      the
      date on which any such Registration Default shall occur to, but excluding,
      the
      earlier of (1) the date on which all Registration Defaults have been cured
      or
      (2) the date on which all the Notes and Exchange Notes otherwise become freely
      transferable by Holders other than affiliates of the Issuer without further
      registration under the Securities Act.

     

    Notwithstanding
      the foregoing, (1) the amount of Liquidated Damages payable shall not increase
      more than by the foregoing rates because more than one Registration Default
      has
      occurred and is pending and (2) a Holder of Notes or Exchange Notes who is
      not
      entitled to the benefits of the Shelf Registration Statement (i.e.,
      such
      Holder has not elected to include information) shall not be entitled to
      Liquidated Damages with respect to a Registration Default that pertains to
      the
      Shelf Registration Statement.

     

    (b)  So
      long
      as Notes remain outstanding, the Issuer shall notify the Trustee within five
      Business Days after each and every date on which an event occurs in respect
      of
      which Liquidated Damages is required to be paid. Any amounts of Liquidated
      Damages due pursuant to clauses (a)(i), (a)(ii) or (a)(iii) of this
      Section 4 will be payable in cash semi-annually on each June 1 and December
      1 (each a "Damages
      Payment Date"),
      commencing with the first such date occurring after any such Liquidated Damages
      commence to accrue, to Holders to whom regular interest is payable on such
      Damages Payment Date with respect to Notes that are Registrable Securities.
      The
      amount of Liquidated Damages for Registrable Notes will be determined by
      multiplying the applicable rate of Liquidated Damages by the aggregate principal
      amount of all such Registrable Notes outstanding on the Damages Payment Date
      following such Registration Default in the case of the first such payment of
      Liquidated Damages with respect to a Registration Default (and thereafter at
      the
      next succeeding Damages Payment Date until the cure of such Registration
      Default), multiplied by a fraction, the numerator of which is the number of
      days
      such Liquidated Damages rate was applicable during such period (determined
      on
      the basis of a 360-day year comprised of twelve 30-day months and, in the case
      of a partial month, the actual number of days elapsed), and the denominator
      of
      which is 360.

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

    Section
      5.  Registration
      Procedures.

     

    In
      connection with the filing of any Registration Statement pursuant to Section
      2
      or 3 hereof, the Issuer shall effect such registrations to permit the sale
      of
      the securities covered thereby in accordance with the intended method or methods
      of disposition thereof, and pursuant thereto and in connection with any
      Registration Statement filed by the Issuer hereunder, the Issuer
      shall:

     

    (a)  Prepare
      and file with the Commission the Registration Statement or Registration
      Statements prescribed by Section 2 or 3 hereof, and use its reasonable best
      efforts to cause each such Registration Statement to become effective and remain
      effective as provided herein; provided,
      however,
      that if
      (1) such filing is pursuant to Section 3 hereof, or (2) a Prospectus
      contained in the Exchange Offer Registration Statement filed pursuant to Section
      2 hereof is required to be delivered under the Securities Act by any
      Participating Broker-Dealer who seeks to sell Exchange Notes during the
      Applicable Period relating thereto, before filing any Registration Statement
      or
      Prospectus or any amendments or supplements thereto, the Issuer shall furnish
      to
      and afford the Holders of the Registrable Notes covered by such Registration
      Statement or each such Participating Broker-Dealer, as the case may be, its
      counsel (if such counsel is known to the Issuer) and the managing underwriters,
      if any, a reasonable opportunity to review copies of all such documents
      (including copies of any documents to be incorporated by reference therein
      and
      all exhibits thereto) proposed to be filed (in each case at least five Business
      Days prior to such filing or such later date as is reasonable under the
      circumstances). The Issuer shall not file any Registration Statement or
      Prospectus or any amendments or supplements thereto if the Holders of a majority
      in aggregate principal amount of the Registrable Notes covered by such
      Registration Statement, or any such Participating Broker-Dealer, as the case
      may
      be, its counsel, or the managing underwriters, if any, shall reasonably object
      on a timely basis.

     

    (b)  Prepare
      and file with the Commission such amendments and post-effective amendments
      to
      each Shelf Registration Statement or Exchange Offer Registration Statement,
      as
      the case may be, as may be necessary to keep such Registration Statement
      continuously effective for the Effectiveness Period or the Applicable Period,
      as
      the case may be, subject to any Delay Periods; cause the related Prospectus
      to
      be supplemented by any Prospectus supplement required by applicable law, and
      as
      so supplemented to be filed pursuant to Rule 424 (or any similar provisions
      then
      in force) promulgated under the Securities Act; and comply with the provisions
      of the Securities Act and the Exchange Act applicable to it with respect to
      the
      disposition of all securities covered by such Registration Statement as so
      amended or in such Prospectus as so supplemented and with respect to the
      subsequent resale of any securities being sold by a Participating Broker-Dealer
      covered by any such Prospectus, in each case, in accordance with the intended
      methods of distribution set forth in such Registration Statement or Prospectus,
      as so amended.

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

     

    (c)  If
      (1) a
      Shelf Registration is filed pursuant to Section 3 hereof, or (2) a
      Prospectus contained in the Exchange Offer Registration Statement filed pursuant
      to Section 2 hereof is required to be delivered under the Securities Act by
      any
      Participating Broker-Dealer who seeks to sell Exchange Notes during the
      Applicable Period relating thereto from whom the Issuer has received written
      notice that such Broker-Dealer will be a Participating Broker-Dealer in the
      applicable Exchange Offer, notify the selling Holders of Registrable Notes,
      or
      each such Participating Broker-Dealer, as the case may be, their counsel and
      the
      managing underwriters, if any, as promptly as possible, and, if requested by
      any
      such Person, confirm such notice in writing, (i) when a Prospectus or any
      Prospectus supplement or post-effective amendment has been filed, and, with
      respect to a Registration Statement or any post-effective amendment, when the
      same has become effective under the Securities Act (including in such notice
      a
      written statement that any Holder may, upon request, obtain, at the sole expense
      of the Issuer, one conformed copy of such Registration Statement or
      post-effective amendment including financial statements and schedules, documents
      incorporated or deemed to be incorporated by reference and exhibits),
      (ii) of the issuance by the Commission of any stop order suspending the
      effectiveness of a Registration Statement or of any order preventing or
      suspending the use of any preliminary prospectus or the initiation of any
      proceedings for that purpose, (iii) if at any time when a Prospectus is
      required by the Securities Act to be delivered in connection with sales of
      the
      Registrable Notes or resales of Exchange Notes by Participating Broker-Dealers
      the representations and warranties of the Issuer contained in any agreement
      (including any underwriting agreement) contemplated by Section 5(m)(i) hereof
      cease to be true and correct in all material respects, (iv) of the receipt
      by the Issuer of any notification with respect to the suspension of the
      qualification or exemption from qualification of a Registration Statement or
      any
      of the Registrable Notes or the Exchange Notes for offer or sale in any
      jurisdiction, or the initiation or threatening of any proceeding for such
      purpose, (v) of the happening of any event, the existence of any condition
      or any information becoming known to the Issuer that makes any statement made
      in
      such Registration Statement or related Prospectus or any document incorporated
      or deemed to be incorporated therein by reference untrue in any material respect
      or that requires the making of any changes in or amendments or supplements
      to
      such Registration Statement, Prospectus or documents so that, in the case of
      the
      Registration Statement, it will not contain any untrue statement of a material
      fact or omit to state any material fact required to be stated therein or
      necessary to make the statements therein not misleading, and that in the case
      of
      the Prospectus, it will not contain any untrue statement of a material fact
      or
      omit to state any material fact required to be stated therein or necessary
      to
      make the statements therein, in the light of the circumstances under which
      they
      were made, not misleading, and (vi) of the Issuer's determination that a
      post-effective amendment to a Registration Statement would be
      appropriate.

     

    (d)  If
      (1) a
      Shelf Registration is filed pursuant to Section 3 hereof, or (2) a
      Prospectus contained in the Exchange Offer Registration Statement filed pursuant
      to Section 2 hereof is required to be delivered under the Securities Act by
      any
      Participating Broker-Dealer who seeks to sell Exchange Notes during the
      Applicable Period, use its reasonable best efforts to prevent the issuance
      of
      any order suspending the effectiveness of a Registration Statement or of any
      order preventing or suspending the use of a Prospectus or suspending the
      qualification (or exemption from qualification) of any of the Registrable Notes
      or the Exchange Notes, as the case may be, for sale in any jurisdiction, and,
      if
      any such order is issued, to use its reasonable best efforts to obtain the
      withdrawal of any such order at the earliest practicable moment.

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    (e)  If
      (1) a Shelf Registration is filed pursuant to Section 3 hereof or
      (2) a Prospectus contained in the Exchange Offer Registration Statement
      filed pursuant to Section 2 hereof is required to be delivered under the
      Securities Act by any Participating Broker-Dealer who seeks to sell Exchange
      Notes during the Applicable Period and if reasonably requested by the managing
      underwriter or underwriters (if any), the Holders of a majority in aggregate
      principal amount of the Registrable Notes covered by such Registration Statement
      or any Participating Broker-Dealer, as the case may be, (i) promptly
      incorporate in such Registration Statement or Prospectus a prospectus supplement
      or post-effective amendment such information as the managing underwriter or
      underwriters (if any), such Holders or any Participating Broker-Dealer, as
      the
      case may be (based upon advice of counsel), determine is reasonably necessary
      to
      be included therein and (ii) make all required filings of such prospectus
      supplement or such post-effective amendment as soon as practicable after the
      Issuer has received notification of the matters to be incorporated in such
      prospectus supplement or post-effective amendment; provided,
      however,
      that
      the Issuer shall not be required to take any action hereunder that would, in
      the
      written opinion of counsel to the Issuer, violate applicable laws.

     

    (f)  If
      (1) a
      Shelf Registration is filed pursuant to Section 3 hereof or (2) a
      Prospectus contained in the Exchange Offer Registration Statement filed pursuant
      to Section 2 hereof is required to be delivered under the Securities Act by
      any
      Participating Broker-Dealer who seeks to sell Exchange Notes during the
      Applicable Period, furnish to each selling Holder of Registrable Notes or each
      such Participating Broker-Dealer, as the case may be, who so requests, its
      counsel and each managing underwriter, if any, at the sole expense of the
      Issuer, one conformed copy of the Registration Statement or Registration
      Statements and each post-effective amendment thereto, including financial
      statements and schedules, and, if requested, all documents incorporated or
      deemed to be incorporated therein by reference and all exhibits.

     

    (g)  If
      (1) a
      Shelf Registration is filed pursuant to Section 3 hereof, or (2) a
      Prospectus contained in the Exchange Offer Registration Statement filed pursuant
      to Section 2 hereof is required to be delivered under the Securities Act by
      any
      Participating Broker-Dealer who seeks to sell Exchange Notes during the
      Applicable Period, deliver to each selling Holder of Registrable Notes or each
      such Participating Broker-Dealer, as the case may be, its respective counsel,
      and the underwriters, if any, at the sole expense of the Issuer, as many copies
      of the Prospectus or Prospectuses (including each form of preliminary
      prospectus) and each amendment or supplement thereto and any documents
      incorporated by reference therein as such Persons may reasonably request; and,
      subject to the last paragraph of this Section 5, the Issuer hereby consents
      to the use of such Prospectus and each amendment or supplement thereto by each
      of the selling Holders of Registrable Notes or each such Participating
      Broker-Dealer, as the case may be, and the underwriters or agents, if any,
      and
      dealers (if any), in connection with the offering and sale of the Registrable
      Notes covered by, or the sale by Participating Broker-Dealers of the Exchange
      Notes pursuant to, such Prospectus and any amendment or supplement
      thereto.

     

    (h)  Prior
      to
      any public offering of Registrable Notes or Exchange Notes or any delivery
      of a
      Prospectus contained in the Exchange Offer Registration Statement by any
      Participating Broker-Dealer who seeks to sell Exchange Notes during the
      Applicable Period, use its reasonable best efforts to register or qualify,
      and
      to cooperate with the selling Holders of Registrable Notes or each such
      Participating Broker-Dealer, as the case may be, the managing underwriter or
      underwriters, if any, and its respective counsel in connection with the
      registration or qualification (or exemption from such registration or
      qualification) of such Registrable Notes or Exchange Notes, as the case may
      be,
      for offer and sale under the securities or state “blue sky” laws of such
      jurisdictions within the United States as any selling Holder, Participating
      Broker-Dealer, or the managing underwriter or underwriters reasonably request;
      provided,
      however,
      that
      where Exchange Notes or Registrable Notes are offered other than through an
      underwritten offering, the Issuer agrees to use its reasonable best efforts
      to
      cause the Issuer's counsel to perform Blue Sky investigations and file
      registrations and qualifications required to be filed pursuant to this Section
      5(h); keep each such registration or qualification (or exemption therefrom)
      effective during the period such Registration Statement is required to be kept
      effective and do any and all other acts or things reasonably necessary or
      advisable to enable the disposition in such jurisdictions of such Exchange
      Notes
      or Registrable Notes covered by the applicable Registration Statement;
provided,
      however,
      that
      the Issuer shall not be required to (A) qualify generally to do business in
      any
      jurisdiction where it is not then so qualified, (B) take any action that would
      subject it to general service of process in any such jurisdiction where it
      is
      not then so subject or (C) subject itself to taxation in excess of a nominal
      dollar amount in any such jurisdiction where it is not then so
      subject.

     

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

    

     

    (i)  If
      a
      Shelf Registration is filed pursuant to Section 3 hereof, cooperate with
      the selling Holders of Registrable Notes and the managing underwriter or
      underwriters, if any, to facilitate the timely preparation and delivery of
      certificates representing Registrable Notes to be sold, which certificates
      shall
      not bear any restrictive legends and shall be in a form eligible for deposit
      with The Depository Trust Company and enable such Registrable Notes to be in
      such denominations and registered in such names as the managing underwriter
      or
      underwriters, if any, or selling Holders may request at least five Business
      Days
      prior to any sale of such Registrable Notes or Exchange Notes.

     

    (j)  Use
      its
      reasonable best efforts to cause the Registrable Notes or Exchange Notes covered
      by any Registration Statement to be registered with or approved by such other
      governmental agencies or authorities as may be reasonably necessary to enable
      the seller or sellers thereof or the underwriter or underwriters, if any, to
      consummate the disposition of such Registrable Notes or Exchange Notes, except
      as may be required solely as a consequence of the nature of such selling
      Holder's business, in which case the Issuer will cooperate in all reasonable
      respects with the filing of such Registration Statement and the granting of
      such
      approvals.

     

    (k)  If
      (1) a
      Shelf Registration is filed pursuant to Section 3 hereof, or (2) a
      Prospectus contained in the Exchange Offer Registration Statement filed pursuant
      to Section 2 hereof is required to be delivered under the Securities Act by
      any
      Participating Broker-Dealer who seeks to sell Exchange Notes during the
      Applicable Period, upon the occurrence of any event contemplated by Section
      5(c)(v) or 5(c)(vi) hereof, as promptly as practicable prepare and (subject
      to
      Section 5(a) and the penultimate paragraph of this Section 5) file
      with the Commission, at the sole expense of the Issuer, a supplement or
      post-effective amendment to the Registration Statement or a supplement to the
      related Prospectus or any document incorporated or deemed to be incorporated
      therein by reference, or file any other required document so that, as thereafter
      delivered to the purchasers of the Registrable Notes being sold thereunder
      or to
      the purchasers of the Exchange Notes to whom such Prospectus will be delivered
      by a Participating Broker-Dealer, any such Prospectus will not contain an untrue
      statement of a material fact or omit to state a material fact required to be
      stated therein or necessary to make the statements therein, in the light of
      the
      circumstances under which they were made, not misleading.

     

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

    

     

    (l)  Prior
      to
      the effective date of the first Registration Statement relating to the
      Registrable Notes, (i) provide the Trustee with certificates for the
      Registrable Notes in a form eligible for deposit with The Depository Trust
      Company and (ii) provide CUSIP numbers for the Registrable
      Notes.

     

    (m)  In
      connection with any underwritten offering of Registrable Notes pursuant to
      a
      Shelf Registration, enter into an underwriting agreement as is customary in
      underwritten offerings of debt securities similar to the Notes and take all
      such
      other actions as are reasonably requested by the managing underwriter or
      underwriters in order to expedite or facilitate the registration or the
      disposition of such Registrable Notes and, in such connection, (i) make
      such representations and warranties to, and covenants with, the underwriters
      with respect to the business of the Issuer and its subsidiaries, as then
      conducted (including any acquired business, properties or entity, if
      applicable), and the Registration Statement, Prospectus and documents, if any,
      incorporated or deemed to be incorporated by reference therein, in each case,
      as
      are customarily made by issuers to underwriters in underwritten offerings of
      debt securities similar to the Notes, and confirm the same in writing if and
      when requested; (ii) use its reasonable best efforts to obtain the written
      opinions of counsel to the Issuer and written updates thereof in form, scope
      and
      substance reasonably satisfactory to the managing underwriter or underwriters,
      addressed to the underwriters covering the matters customarily covered in
      opinions requested in underwritten offerings and such other matters as may
      be
      reasonably requested by the managing underwriter or underwriters; (iii) use
      its reasonable best efforts to obtain "cold comfort" letters and updates thereof
      in form, scope and substance reasonably satisfactory to the managing underwriter
      or underwriters from the independent certified public accountants of the Issuer
      (and, if necessary, any other independent certified public accountants of any
      subsidiary of the Issuer or of any business acquired by the Issuer for which
      financial statements and financial data are, or are required to be, included
      or
      incorporated by reference in the Registration Statement), addressed to each
      of
      the underwriters, such letters to be in customary form and covering matters
      of
      the type customarily covered in "cold comfort" letters in connection with
      underwritten offerings; and (iv) if an underwriting agreement is entered
      into, the same shall contain indemnification provisions and procedures no less
      favorable than those set forth in Section 7 hereof (or such other
      provisions and procedures acceptable to Holders of a majority in aggregate
      principal amount of Registrable Notes covered by such Registration Statement
      and
      the managing underwriter or underwriters or agents) with respect to all parties
      to be indemnified pursuant to said Section; provided
      that the
      Issuer shall not be required to provide indemnification to any underwriter
      selected in accordance with the provisions of Section 9 hereof with respect
      to
      information relating to such underwriter furnished in writing to the Issuer
      by
      or on behalf of such underwriter expressly for inclusion in such Registration
      Statement. The above shall be done at each closing under such underwriting
      agreement, or as and to the extent required thereunder.

     

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

     

    (n)  If
      (1) a
      Shelf Registration is filed pursuant to Section 3 hereof or (2) a
      Prospectus contained in the Exchange Offer Registration Statement filed pursuant
      to Section 2 hereof is required to be delivered under the Securities Act by
      any
      Participating Broker-Dealer who seeks to sell Exchange Notes during the
      Applicable Period, make available for inspection by any selling Holder of such
      Registrable Notes being sold or each such Participating Broker-Dealer, as the
      case may be, any underwriter participating in any such disposition of
      Registrable Notes, if any, and any attorney, accountant or other agent retained
      by any such selling Holder or each such Participating Broker-Dealer, as the
      case
      may be, or underwriter (collectively, the "Inspectors"),
      at
      the offices where normally kept, during reasonable business hours, all financial
      and other records, pertinent corporate documents and instruments of the Issuer
      and its subsidiaries (collectively, the "Records")
      as
      shall be reasonably necessary to enable them to exercise any applicable due
      diligence responsibilities, and cause the officers, directors and employees
      of
      the Issuer and its subsidiaries to supply all information reasonably requested
      by any such Inspector in connection with such Registration Statement and
      Prospectus. Each Inspector shall agree in writing that it will keep the Records
      confidential and that it will not disclose, or use in connection with any market
      transactions in violation of any applicable securities laws, any Records that
      the Issuer determines, in good faith, to be confidential and that it notifies
      the Inspectors in writing are confidential unless (i) the disclosure of
      such Records is necessary to avoid or correct a misstatement or omission in
      such
      Registration Statement or Prospectus, (ii) the release of such Records is
      ordered pursuant to a subpoena or other order from a court of competent
      jurisdiction, (iii) disclosure of such information is necessary or
      advisable in the opinion of counsel for an Inspector in connection with any
      action, claim, suit or proceeding, directly or indirectly, involving or
      potentially involving such Inspector and arising out of, based upon, relating
      to, or involving this Agreement or the Purchase Agreements, or any transactions
      contemplated hereby or thereby or arising hereunder or thereunder, or
      (iv) the information in such Records has been made generally available to
      the public; provided,
      however,
      that
      (i) each Inspector shall agree to use reasonable best efforts to provide
      notice to the Issuer of the potential disclosure of any information by such
      Inspector pursuant to clause (i), (ii) or (iii) of this sentence to permit
      the
      Issuer to obtain a protective order (or waive the provisions of this paragraph
      (n)) and (ii) each such Inspector shall take such actions as are reasonably
      necessary to protect the confidentiality of such information (if practicable)
      to
      the extent such action is otherwise not inconsistent with, an impairment of
      or
      in derogation of the rights and interests of the Holder or any
      Inspector.

     

    (o)  Provide
      an indenture trustee for the Registrable Notes or the Exchange Notes, as the
      case may be, and cause the Indenture or the trust indenture provided for in
      Section 2(a) hereof to be qualified under the TIA not later than the effective
      date of the Exchange Offer or the first Registration Statement relating to
      the
      Registrable Notes; and in connection therewith, cooperate with the trustee
      under
      any such indenture and the Holders of the Registrable Notes or Exchange Notes,
      as applicable, to effect such changes to such indenture as may be required
      for
      such indenture to be so qualified in accordance with the terms of the TIA;
      and
      execute, and use its reasonable best efforts to cause such trustee to execute,
      all documents as may be required to effect such changes, and all other forms
      and
      documents required to be filed with the Commission to enable such indenture
      to
      be so qualified in a timely manner.

     

    (p)  Comply
      with all applicable rules and regulations of the Commission and make generally
      available to the Issuer's security holders earnings statements satisfying the
      provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or
      any similar rule promulgated under the Securities Act) no later than 45 days
      after the end of any 12-month period (or 90 days after the end of any 12-month
      period if such period is a fiscal year) (i) commencing at the end of any
      fiscal quarter in which Registrable Notes or Exchange Notes are sold to
      underwriters in a firm commitment or best efforts underwritten offering and
      (ii) if not sold to underwriters in such an offering, commencing on the
      first day of the first fiscal quarter of the Issuer after the effective date
      of
      a Registration Statement, which statements shall cover said 12-month periods
      consistent with the requirements of Rule 158.

     

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

     

    (q)  If
      the
      Exchange Offer or a Private Exchange is to be consummated, upon delivery of
      the
      Registrable Notes by Holders to the Issuer (or to such other Person as directed
      by the Issuer) in exchange for the Exchange Notes or the Private Exchange Notes,
      as the case may be, mark, or cause to be marked, on such Registrable Notes
      that
      such Registrable Notes are being cancelled in exchange for the Exchange Notes
      or
      the Private Exchange Notes, as the case may be; provided
      that in
      no event shall such Registrable Notes be marked as paid or otherwise
      satisfied.

     

    (r)  Cooperate
      with each seller of Registrable Notes covered by any Registration Statement
      and
      each underwriter, if any, participating in the disposition of such Registrable
      Notes and their respective counsel in connection with any filings required
      to be
      made with the National Association of Securities Dealers, Inc. (the
      "NASD").

     

    (s)  Use
      its
      reasonable best efforts to take all other steps reasonably necessary or
      advisable to effect the registration of the Exchange Notes and/or Registrable
      Notes covered by a Registration Statement contemplated hereby.

     

    The
      Issuer may require each seller of Registrable Notes or Exchange Notes as to
      which any registration is being effected to furnish to the Issuer such
      information regarding such seller and the distribution of such Registrable
      Notes
      or Exchange Notes as the Issuer may, from time to time, reasonably request.
      The
      Issuer may exclude from such registration the Registrable Notes of any seller
      so
      long as such seller fails to furnish such information within a reasonable time
      after receiving such request and in the event of such an exclusion, the Issuer
      shall have no further obligation under this Agreement (including, without
      limitation, the obligations under Section 4) with respect to such seller or
      any subsequent Holder of such Registrable Notes. Each seller as to which any
      Shelf Registration is being effected agrees to furnish promptly to the Issuer
      all information required to be disclosed in order to make any information
      previously furnished to the Issuer by such seller not materially
      misleading.

     

    If
      any
      such Registration Statement refers to any Holder by name or otherwise as the
      holder of any securities of the Issuer, then such Holder shall have the right
      to
      require (i) the insertion therein of language, in form and substance reasonably
      satisfactory to such Holder, to the effect that the holding by such Holder
      of
      such securities is not to be construed as a recommendation by such Holder of
      the
      investment quality of the securities covered thereby and that such holding
      does
      not imply that such Holder will assist in meeting any future financial
      requirements of the Issuer, or (ii) in the event that such reference to such
      Holder by name or otherwise is not required by the Securities Act or any similar
      federal statute then in force, the deletion of the reference to such Holder
      in
      any amendment or supplement to the applicable Registration Statement filed
      or
      prepared subsequent to the time that such reference ceases to be
      required.

     

    
      
        
        

      

      
        17

        
          

        

      

      
        
        

      

    

     

    Each
      Holder of Registrable Notes and each Participating Broker-Dealer agrees by
      acquisition of such Registrable Notes or Exchange Notes that, upon actual
      receipt of any notice from the Issuer (x) of the happening of any event of
      the
      kind described in Section 5(c)(ii), 5(c)(iii), 5(c)(iv), or 5(c)(v) hereof,
      or (y) that the Board of Directors of the Issuer (the "Board
      of Directors")
      has
      resolved that the Issuer has a bona
      fide
      business
      purpose for doing so, then the Issuer may delay the filing or the effectiveness
      of the Exchange Offer Registration Statement or the Shelf Registration Statement
      (if not then filed or effective, as applicable) and shall not be required to
      maintain the effectiveness thereof or amend or supplement the Exchange Offer
      Registration Statement or the Shelf Registration, in all cases, for a period
      (a
      "Delay
      Period")
      expiring upon the earlier to occur of (i) in the case of the immediately
      preceding clause (x), such Holder's or Participating Broker-Dealer's
      receipt of the copies of the supplemented or amended Prospectus contemplated
      by
      Section 5(k) hereof or until it is advised in writing (the "Advice")
      by the
      Issuer that the use of the applicable Prospectus may be resumed, and has
      received copies of any amendments or supplements thereto or (ii) in the
      case of the immediately preceding clause (y), the date which is the earlier
      of (A) the date on which such business purpose ceases to interfere with the
      Issuer's obligations to file or maintain the effectiveness of any such
      Registration Statement pursuant to this Agreement or (B) 60 days after the
      Issuer notifies the Holders of such good faith determination. There shall not
      be
      more than 60 days of Delay Periods during any 12-month period. Each of the
      Effectiveness Period and the Applicable Period, if applicable, shall be extended
      by the number of days during any Delay Period. 

     

    In
      the
      event of any Delay Period pursuant to clause (y) of the preceding paragraph,
      notice shall be given as soon as practicable after the Board of Directors makes
      such a determination of the need for a Delay Period and shall state, to the
      extent practicable, an estimate of the duration of such Delay Period and shall
      advise the recipient thereof of the agreement of such Holder provided in the
      next succeeding sentence. Each Holder, by his acceptance of any Registrable
      Note, agrees that during any Delay Period, each Holder will discontinue
      disposition of such Notes or Exchange Notes covered by such Registration
      Statement or Prospectus or Exchange Notes to be sold by such Holder or
      Participating Broker-Dealer, as the case may be.

     

    Section
      6.  Registration
      Expenses.

     

    All
      fees
      and expenses incident to the performance of or compliance with this Agreement
      by
      the Issuer (other than any underwriting discounts or commissions and transfer
      taxes) shall be borne by the Issuer, whether or not the Exchange Offer
      Registration Statement or the Shelf Registration is filed or becomes effective
      or the Exchange Offer is consummated, including, without limitation,
      (i) all registration and filing fees (including, without limitation,
      (A) fees with respect to filings required to be made with the NASD in
      connection with an underwritten offering and (B) fees and expenses of compliance
      with state securities or Blue Sky laws (including, without limitation,
      reasonable fees and disbursements of counsel in connection with Blue Sky
      qualifications of the Registrable Notes or Exchange Notes and determination
      of
      the eligibility of the Registrable Notes or Exchange Notes for investment under
      the laws of such jurisdictions (x) where the holders of Registrable Notes
      are located, in the case of an Exchange Offer, or (y) as provided in
      Section 5(h) hereof, in the case of a Shelf Registration or in the case of
      Exchange Notes to be sold by a Participating Broker-Dealer during the Applicable
      Period)), (ii) printing expenses, including, without limitation, expenses
      of printing certificates for Registrable Notes or Exchange Notes in a form
      eligible for deposit with The Depository Trust Company and of printing
      prospectuses if the printing of prospectuses is requested by the managing
      underwriter or underwriters, if any, or by the Holders of a majority in
      aggregate principal amount of the Registrable Notes included in any Registration
      Statement or in respect of Exchange Notes to be sold by any Participating
      Broker-Dealer during the Applicable Period, as the case may be,
      (iii) messenger, telephone and delivery expenses, (iv) fees and
      disbursements of counsel for the Issuer and reasonable fees and disbursements
      of
      one special counsel for all of the sellers of Registrable Notes (which shall
      be
      reasonably acceptable to the Issuer) (exclusive of any counsel retained pursuant
      to Section 7 hereof), (v) fees and disbursements of all independent
      certified public accountants referred to in Section 5(m)(iii) hereof (including,
      without limitation, the expenses of any special audit and "cold comfort" letters
      required by or incident to such performance), (vi) Securities Act liability
      insurance, if the Issuer desires such insurance, (vii) fees and expenses of
      all other Persons retained by the Issuer, (viii) internal expenses of the
      Issuer (including, without limitation, all salaries and expenses of officers
      and
      employees of the Issuer performing legal or accounting duties), (ix) the
      expense of any annual audit, (x) the fees and expenses incurred in
      connection with the listing of the securities to be registered on any securities
      exchange, and the obtaining of a rating of the securities, in each case, if
      applicable, and (xi) the expenses relating to printing, word processing and
      distributing all Registration Statements, underwriting agreements, indentures
      and any other documents necessary in order to comply with this Agreement.
      Notwithstanding the foregoing or anything to the contrary, each Holder shall
      pay
      all underwriting discounts and commissions of any underwriters with respect
      to
      any Registrable Notes sold by or on behalf of it.

     

    
      
        
        

      

      
        18

        
          

        

      

      
        
        

      

    

     

    Section
      7.  Indemnification.

     

    (a)  The
      Issuer agrees to indemnify and hold harmless, to the extent permitted by law,
      each Holder of Registrable Notes and each Participating Broker-Dealer selling
      Exchange Notes during the Applicable Period, each Person, if any, who controls
      any such Person within the meaning of Section 15 of the Securities Act or
      Section 20(a) of the Exchange Act, the agents, employees, officers and
      directors of each Holder and each such Participating Broker-Dealer and the
      agents, employees, officers and directors of any such controlling Person (each,
      a "Participant")
      from
      and against any and all losses, liabilities, claims, damages and expenses
      (including, but not limited to, reasonable attorneys' fees and any and all
      reasonable out-of-pocket expenses actually incurred in investigating, preparing
      or defending against any litigation, commenced or threatened, or any claim
      whatsoever, and any and all reasonable amounts paid in settlement of any claim
      or litigation (in the manner set forth in clause (c) below)) (collectively,
      "Losses")
      to
      which they or any of them may become subject under the Securities Act, the
      Exchange Act or otherwise insofar as such Losses (or actions in respect thereof)
      arise out of or are based upon any untrue statement or alleged untrue statement
      of a material fact contained in any Registration Statement (or any amendment
      thereto) or Prospectus (as amended or supplemented if the Issuer shall have
      furnished any amendments or supplements thereto) or any preliminary prospectus,
      or caused by, arising out of or based upon any omission or alleged omission
      to
      state therein a material fact required to be stated therein or necessary to
      make
      the statements therein, in the case of the Prospectus, in the light of the
      circumstances under which they were made, not misleading, provided
      that (i)
      the foregoing indemnity shall not be available to any Participant insofar as
      such Losses are caused by any untrue statement or omission or alleged untrue
      statement or omission made in reliance upon and in conformity with information
      relating to such Participant furnished to the Issuer in writing by or on behalf
      of such Participant expressly for use therein, and (ii) that the foregoing
      indemnity with respect to any Prospectus shall not inure to the benefit of
      any
      Participant from whom the Person asserting such Losses purchased Registrable
      Notes if (x) it is established in the related proceeding that such
      Participant failed to send or give a copy of the Prospectus (as amended or
      supplemented if such amendment or supplement was furnished to such Participant
      prior to the written confirmation of such sale) to such Person with or prior
      to
      the written confirmation of such sale, if required by applicable law, and
      (y) the untrue statement or omission or alleged untrue statement or
      omission was completely corrected in the Prospectus (as amended or supplemented
      if amended or supplemented as aforesaid) and such Prospectus does not contain
      any other untrue statement or omission or alleged untrue statement or omission
      that was the subject matter of the related proceeding. This indemnity agreement
      will be in addition to any liability that the Issuer may otherwise have,
      including, but not limited to, liability under this Agreement.

     

    
      
        
        

      

      
        19

        
          

        

      

      
        
        

      

    

     

    (b)  Each
      Participant agrees, severally and not jointly, to indemnify and hold harmless
      (in the same manner and to the same extent set forth in subsection 7(a))the
      Issuer, each Person, if any, who controls the Issuer within the meaning of
      Section 15 of the Securities Act or Section 20(a) of the Exchange Act,
      and each of its agents, employees, officers and directors and the agents,
      employees, officers and directors of any such controlling Person from and
      against any Losses to which they or any of them may become subject under the
      Securities Act, the Exchange Act or otherwise insofar as such Losses (or actions
      in respect thereof) arise out of or are based upon any untrue statement or
      alleged untrue statement of a material fact contained in any Registration
      Statement (or any amendment thereto) or Prospectus (as amended or supplemented
      if the Issuer shall have furnished any amendments or supplements thereto) or
      any
      preliminary prospectus, or caused by, arising out of or based upon any omission
      or alleged omission to state therein a material fact required to be stated
      therein or necessary to make the statements therein, in the case of the
      Prospectus, in the light of the circumstances under which they were made, not
      misleading, in each case to the extent, but only to the extent, that any such
      Loss arises out of or is based upon any untrue statement or alleged untrue
      statement or omission or alleged omission made in reliance upon and in
      conformity with information relating to such Participant furnished in writing
      to
      the Issuer by or on behalf of such Participant expressly for use
      therein.

     

    (c)  Promptly
      after receipt by an indemnified party under subsection 7(a) or 7(b) above of
      notice of the commencement of any action, suit or proceeding (collectively,
      an
      "action"),
      such
      indemnified party shall, if a claim in respect thereof is to be made against
      the
      indemnifying party under such subsection, notify each party against whom
      indemnification is to be sought in writing of the commencement of such action
      (but the failure so to notify an indemnifying party shall not relieve such
      indemnifying party from any liability that it may have under this Section 7
      except to the extent that it has been prejudiced in any material respect by
      such
      failure). In case any such action is brought against any indemnified party,
      and
      it notifies an indemnifying party of the commencement of such action, the
      indemnifying party will be entitled to participate in such action, and to the
      extent it may elect by written notice delivered to the indemnified party
      promptly after receiving the aforesaid notice from such indemnified party,
      to
      assume the defense of such action with counsel satisfactory to such indemnified
      party. Notwithstanding the foregoing, the indemnified party or parties shall
      have the right to employ its or their own counsel in any such action, but the
      reasonable fees and expenses of such counsel shall be at the expense of such
      indemnified party or parties unless (i) the employment of such counsel shall
      have been authorized in writing by the indemnifying parties in connection with
      the defense of such action, (ii) the indemnifying parties shall not have
      employed counsel to take charge of the defense of such action within a
      reasonable time after notice of commencement of the action, or (iii) the named
      parties to such action (including any impleaded parties) include such
      indemnified party and the indemnifying party or parties (or such indemnifying
      parties have assumed the defense of such action), and such indemnified party
      or
      parties shall have reasonably concluded, that counsel selected by the
      indemnifying party has a conflict of interest in representing both the
      indemnifying party and the indemnified party (in which case the indemnifying
      parties shall not have the right to direct the defense of such action on behalf
      of the indemnified party or parties), in any of which events such reasonable
      fees and expenses of counsel shall be borne by the indemnifying parties. In
      no
      event shall the indemnifying party be liable for the fees and expenses of more
      than one counsel (together with appropriate local counsel) at any time for
      all
      indemnified parties in connection with any one action or separate but
      substantially similar or related actions arising in the same jurisdiction out
      of
      the same general allegations or circumstances. Any such separate firm for the
      Participants shall be designated in writing by Participants who sold a majority
      in interest of Registrable Notes sold by all such Participants and shall be
      reasonably acceptable to the Issuer and any such separate firm for the Issuer,
      its affiliates, officers, directors, representatives, employees and agents
      and
      such control Person of the Issuer shall be designated in writing by the Issuer
      and shall be reasonable acceptable to the Holders. An indemnifying party shall
      not be liable for any settlement of any claim or action effected without its
      written consent, which consent may not be unreasonably withheld. No indemnifying
      party shall, without the prior written consent of the indemnified party, effect
      any settlement of any pending or threatened proceeding in respect of which
      any
      indemnified party is or could have been a party and indemnity could have been
      sought hereunder by such indemnified party, unless such settlement includes
      an
      unconditional release of such indemnified party from all liability on claims
      that are the subject matter of such proceeding.

     

    
      
        
        

      

      
        20

        
          

        

      

      
        
        

      

    

     

    (d)  In
      order
      to provide for contribution in circumstances in which the indemnification
      provided for in this Section 7 is for any reason held to be unavailable from
      the
      indemnifying party, or is insufficient to hold harmless a party indemnified
      under this Section 7, each indemnifying party shall contribute to the amount
      paid or payable by such indemnified party as a result of such aggregate Losses
      (i) in such proportion as is appropriate to reflect the relative benefits
      received by each indemnifying party, on the one hand, and each indemnified
      party, on the other hand, from the sale of the Notes to the Purchaser or the
      Initial Purchasers, as the case may be, or the resale of the Registrable Notes
      by such Holder, as applicable, or (ii) if such allocation is not permitted
      by applicable law, in such proportion as is appropriate to reflect not only
      the
      relative benefits referred to in clause (i) above but also the relative fault
      of
      each indemnified party, on the one hand, and each indemnifying party, on the
      other hand, in connection with the statements or omissions that resulted in
      such
      Losses, as well as any other relevant equitable considerations. The relative
      benefits received by the Issuer, on the one hand, and each Participant, on
      the
      other hand, shall be deemed to be in the same proportion as (x) the total
      proceeds from the sale of the Notes to the Purchaser or the Initial Purchasers,
      as the case may be, (net of discounts and commissions but before deducting
      expenses) received by the Issuer are to (y) the total net profit received by
      such Participant in connection with the sale of the Registrable Notes. The
      relative fault of the parties shall be determined by reference to, among other
      things, whether the untrue or alleged untrue statement of a material fact or
      the
      omission or alleged omission to state a material fact relates to information
      supplied by the Issuer or such Participant and the parties' relative intent,
      knowledge, access to information and opportunity to correct or prevent such
      statement or omission or alleged statement or omission.

     

    
      
        
        

      

      
        21

        
          

        

      

      
        
        

      

    

     

    (e)  The
      parties agree that it would not be just and equitable if contribution pursuant
      to this Section 7 were determined by pro rata allocation or by any other method
      of allocation that does not take into account the equitable considerations
      referred to above. Notwithstanding the provisions of this Section 7, (i) in
      no
      case shall any Participant be required to contribute any amount in excess of
      the
      amount by which the net profit received by such Participant in connection with
      the sale of the Registrable Notes exceeds the amount of any damages that such
      Participant has otherwise been required to pay by reason of any untrue or
      alleged untrue statement or omission or alleged omission and (ii) no person
      guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
      of
      the Securities Act) shall be entitled to contribution from any person who was
      not guilty of such fraudulent misrepresentation. Any party entitled to
      contribution will, promptly after receipt of notice of commencement of any
      action against such party in respect of which a claim for contribution may
      be
      made against another party or parties under this Section 7, notify such party
      or
      parties from whom contribution may be sought, but the omission to so notify
      such
      party or parties shall not relieve the party or parties from whom contribution
      may be sought from any obligation it or they may have under this Section 7
      or
      otherwise, except to the extent that it has been prejudiced in any material
      respect by such failure; provided,
      however,
      that no
      additional notice shall be required with respect to any action for which notice
      has been given under this Section 7 for purposes of indemnification. Anything
      in
      this section to the contrary notwithstanding, no party shall be liable for
      contribution with respect to any action or claim settled without its written
      consent, provided,
      however,
      that
      such written consent was not unreasonably withheld.

     

    Section
      8.  Rules
      144 and 144A.

     

    The
      Issuer covenants that it will file the reports required, if any, to be filed
      by
      it under the Securities Act and the Exchange Act and the rules and regulations
      adopted by the Commission thereunder in a timely manner in accordance with
      the
      requirements of the Securities Act and the Exchange Act and, if at any time
      the
      Issuer is not required to file such reports, it will, upon the request of any
      Holder or beneficial owner of Registrable Notes, make available such information
      necessary to permit sales pursuant to Rule 144A under the Securities Act. The
      Issuer further covenants that for so long as any Registrable Notes remain
      outstanding it will take such further action as any Holder of Registrable Notes
      may reasonably request from time to time to enable such Holder to sell
      Registrable Notes without registration under the Securities Act within the
      limitation of the exemptions provided by (a) Rule 144(k) and Rule 144A under
      the
      Securities Act, as such Rules may be amended from time to time, or (b) any
      similar rule or regulation hereafter adopted by the Commission.

     

    Section
      9.  Underwritten
      Registrations.

     

    If
      any of
      the Registrable Notes covered by any Shelf Registration are to be sold in an
      underwritten offering, the investment banker or investment bankers and manager
      or managers that will manage the offering will be selected by the Holders of
      a
      majority in aggregate principal amount of such Registrable Notes included in
      such offering and shall be reasonably acceptable to the Issuer.

     

    
      
        
        

      

      
        22

        
          

        

      

      
        
        

      

    

     

    No
      Holder
      of Registrable Notes may participate in any underwritten registration hereunder
      if such Holder does not (a) agree to sell such Holder's Registrable Notes
      on the basis provided in any underwriting arrangements approved by the Persons
      entitled hereunder to approve such arrangements and (b) complete and
      execute all questionnaires, powers of attorney, indemnities, underwriting
      agreements and other documents required under the terms of such underwriting
      arrangements.

     

    Section
      10.  Miscellaneous.

     

    (a)  No
      Inconsistent Agreements.
      The
      Issuer has not, as of the date hereof, and shall not have, after the date of
      this Agreement, entered into any agreement with respect to any of its securities
      that is inconsistent with the rights granted to the Holders of Registrable
      Notes
      in this Agreement or otherwise conflicts with the provisions hereof. The rights
      granted to the Holders hereunder do not conflict with and are not inconsistent
      with, in any material respect, the rights granted to the holders of any of
      the
      Issuer's other issued and outstanding securities under any such agreements.
      The
      Issuer has not entered and will not enter into any agreement with respect to
      any
      of its securities which will grant to any Person piggy-back registration rights
      with respect to any Registration Statement.

     

    (b)  Adjustments
      Affecting Registrable Notes.
      The
      Issuer shall not, directly or indirectly, take any action with respect to the
      Registrable Notes as a class that would adversely affect the ability of the
      Holders of Registrable Notes to include such Registrable Notes in a registration
      undertaken pursuant to this Agreement.

     

    (c)  Amendments
      and Waivers.
      The
      provisions of this Agreement may not be amended, modified or supplemented,
      and
      waivers or consents to departures from the provisions hereof may not be given
      except pursuant to a written agreement duly signed and delivered by (I) the
      Issuer and (II)(A) the Holders of not less than a majority in aggregate
      principal amount of the then outstanding Registrable Notes and (B) in
      circumstances that would adversely affect the Participating Broker-Dealers,
      the
      Participating Broker-Dealers holding not less than a majority in aggregate
      principal amount of the Exchange Notes held by all Participating Broker-Dealers;
      provided,
      however,
      that
      Section 7 and this Section 10(c) may not be amended, modified or
      supplemented except pursuant to a written agreement duly signed and delivered
      by
      the Issuer and each Holder and each Participating Broker-Dealer (including
      any
      Person who was a Holder or Participating Broker-Dealer of Registrable Notes
      or
      Exchange Notes, as the case may be, disposed of pursuant to any Registration
      Statement) affected by any such amendment, modification, supplement or waiver.
      Notwithstanding the foregoing, a waiver or consent to depart from the provisions
      hereof with respect to a matter that relates exclusively to the rights of
      Holders of Registrable Notes whose securities are being sold pursuant to a
      Registration Statement and that does not directly or indirectly affect, impair,
      limit or compromise the rights of other Holders of Registrable Notes may be
      given by Holders of at least a majority in aggregate principal amount of the
      Registrable Notes being sold pursuant to such Registration
      Statement.

     

    (d)  Notices.
      All
      notices and other communications (including, without limitation, any notices
      or
      other communications to the Trustee) provided for or permitted hereunder shall
      be made in writing by hand-delivery, registered first-class mail, next-day
      air
      courier or telecopier:

     

    
      
        
        

      

      
        23

        
          

        

      

      
        
        

      

    

     

    (i)  if
      to a
      Holder of the Registrable Notes or any Participating Broker-Dealer, at the
      most
      current address of such Holder or Participating Broker-Dealer, as the case
      may
      be, set forth on the records of the registrar under the Indenture.

     

    (ii)  if
      to the
      Issuer, at the address as follows:

     

    Energy
      XXI Gulf Coast, Inc.

    Suite
      2626

    1021
      Main

    Houston,
      Texas 77002

    Telephone:
      713-351-3000

    Facsimile:
      713-351-3300

    Attention:
      David West Griffin, Chief Financial Officer

     

    (iii)  if
      to the
      Initial Purchasers as follows:

     

    Jefferies
      & Company, Inc.

    520
      Madison Avenue, 12th Floor

    New
      York,
      New York 10022

    Facsimile:
      (212) 284-2280

    Attention:
      General Counsel

     

    BNP
      Paribas Securities Corp.

    787
      Seventh Avenue

    New
      York,
      New York 10019

    Facsimile:
      (212) 841-3183

    Attention:
      Debt Capital Markets

     

    BMO
      Capital Markets Corp.

    3
      Times
      Square, 27th Floor

    New
      York,
      New York 10036

    Telephone:
      (212) 702-1268

    Attention:
      Paul H. Phaneuf, Managing Director

     

    Greenwich
      Capital Markets, Inc.

    600
      Steamboat Road

    Greenwich,
      Connecticut 06830

    Facsimile:
      (203) 427-4534

    Attention:
      Debt Capital Market Syndicate

     

    Capital
      One Southcoast, Inc. 

    909
      Poydras Street. Suite 1000 

    New
      Orleans, Louisiana 70112

    Facsimile:
      (504)
      523-1925

    Attention:
      Patrick Mooney, Senior Vice President

     

    Natexis
      Bleichroeder Inc.

    1345
      Avenue of the Americas, 44th Floor

    New
      York,
      NY 10105

    Facsimile:
      (212) 333 4710

    Attention:
      Capital Markets

     

    
      
        
        

      

      
        24

        
          

        

      

      
        
        

      

    

     

    (iv)  if
      to the
      Purchasers, at the addresses contained in their signature pages.

     

    All
      such
      notices and communications shall be deemed to have been duly given: when
      delivered by hand, if personally delivered; five Business Days after being
      deposited in the mail, postage prepaid, if mailed; when receipt is acknowledged
      by the recipient's telecopier machine, if telecopied; and on the next Business
      Day, if timely delivered to an air courier guaranteeing overnight
      delivery.

     

    Copies
      of
      all such notices, demands or other communications shall be concurrently
      delivered by the Person giving the same to the Trustee at the address and in
      the
      manner specified in such Indenture.

     

    (e)  Successors
      and Assigns.
      This
      Agreement shall inure to the benefit of and be binding upon the successors
      and
      assigns of each of the parties hereto, the Holders and the Participating
      Broker-Dealers; provided,
      however,
      that
      this Agreement shall not inure to the benefit of or be binding upon a successor
      or assign of a Holder unless and to the extent such successor or assign holds
      Registrable Notes.

     

    (f)  Counterparts.
      This
      Agreement may be executed in any number of counterparts and by the parties
      hereto in separate counterparts, each of which when so executed shall be deemed
      to be an original and all of which taken together shall constitute one and
      the
      same agreement.

     

    (g)  Headings.
      The
      headings in this Agreement are for convenience of reference only and shall
      not
      limit or otherwise affect the meaning hereof.

     

    (h)  Governing
      Law; Jurisdiction; Jury Trial.
      This
      Agreement shall be governed by, and construed in accordance with, the laws
      of
      the State of New York. Any legal suit, action or proceeding arising out of
      or
      based upon this Agreement or the transactions contemplated hereby may be
      instituted in the federal courts of the United States of America located in
      the
      Borough of Manhattan in the City of New York or the courts of the State of
      New
      York in each case located in the Borough of Manhattan in the City of New York.
      Each party hereby irrevocably waives, and agrees not to assert in any suit,
      action or proceeding, any claim that it is not personally subject to the
      jurisdiction of any such court, that such suit, action or proceeding is brought
      in an inconvenient forum or that the venue of such suit, action or proceeding
      is
      improper. Each party hereby irrevocably waives personal service of process
      and
      consents to process being served in any such suit, action or proceeding by
      mailing a copy thereof to such party at the address for such notices to it
      under
      this Agreement and agrees that such service shall constitute good and sufficient
      service of process and notice thereof. Nothing contained herein shall be deemed
      to limit in any way any right to serve process in any manner permitted by law.
      Each party hereby irrevocably waives any right it may have, and agrees not
      to
      request, a jury trial for the adjudication of any dispute hereunder or in
      connection with or arising out of this Agreement or any transaction contemplated
      hereby.

     

    
      
        
        

      

      
        25

        
          

        

      

      
        
        

      

    

     

    (i)  Severability.
      If any
      term, provision, covenant or restriction of this Agreement is held by a court
      of
      competent jurisdiction to be invalid, illegal, void or unenforceable, the
      remainder of the terms, provisions, covenants and restrictions set forth herein
      shall remain in full force and effect and shall in no way be affected, impaired
      or invalidated, and the parties hereto shall use their best efforts to find
      and
      employ an alternative means to achieve the same or substantially the same result
      as that contemplated by such term, provision, covenant or restriction. It is
      hereby stipulated and declared to be the intention of the parties that they
      would have executed the remaining terms, provisions, covenants and restrictions
      without including any of such that may be hereafter declared invalid, illegal,
      void or unenforceable.

     

    (j)  Securities
      Held by the Issuer or Its Affiliates.
      Whenever the consent or approval of Holders of a specified percentage of
      Registrable Notes is required hereunder, Registrable Notes held by the Issuer
      or
      any of its affiliates (as such term is defined in Rule 405 under the Securities
      Act) shall not be counted in determining whether such consent or approval was
      given by the Holders of such required percentage.

     

    (k)  Third-Party
      Beneficiaries.
      Holders
      and beneficial owners of Registrable Notes and Participating Broker-Dealers
      are
      intended third-party beneficiaries of this Agreement, and this Agreement may
      be
      enforced by such Persons. No other Person is intended to be, or shall be
      construed as, a third-party beneficiary of this Agreement.

     

    (l)  Attorneys'
      Fees.
      As
      between the parties to this Agreement, in any action or proceeding brought
      to
      enforce any provision of this Agreement, or where any provision hereof is
      validly asserted as a defense, the successful party shall be entitled to recover
      reasonable attorneys' fees actually incurred in addition to its costs and
      expenses and any other available remedy.

     

    (m)  Remedies.
      The
      Issuers acknowledge and agree that any failure by the Issuers to comply with
      their respective obligations under this Agreement may result in material
      irreparable injury to the Initial Purchasers, the Purchasers or the Holders
      for
      which there is no adequate remedy at law, that it will not be possible to
      measure damages for such injuries precisely and that, in the event of any such
      failure, the Initial Purchasers, the Purchasers or any Holder may obtain such
      relief as may be required to specifically enforce the Issuers' obligations
      under
      this Agreement. The Issuers further agree to waive the defense in any action
      for
      specific performance that a remedy at law would be adequate. Notwithstanding
      the
      foregoing, the parties agree that the sole monetary damages payable for a
      violation of the terms of this Agreement shall be such Liquidated
      Damages.

     

    (n)  Entire
      Agreement.
      This
      Agreement, together with the Purchase Agreements and the Indenture, is intended
      by the parties as a final and exclusive statement of the agreement and
      understanding of the parties hereto in respect of the subject matter contained
      herein and therein and any and all prior oral or written agreements,
      representations, or warranties, contracts, understandings, correspondence,
      conversations and memoranda between the Holders on the one hand and the Issuer
      on the other, or between or among any agents, representatives, parents,
      subsidiaries, affiliates, predecessors in interest or successors in interest
      with respect to the subject matter hereof and thereof are merged herein and
      replaced hereby.

     

    
      
        
        

      

      
        26

        
          

        

      

      
        
        

      

    

    
 

    IN
      WITNESS WHEREOF, the parties have executed this Agreement as of the date first
      written above.

     

    ENERGY
      XXI GULF COAST, INC., as
      Issuer

     

     

    By:
      _________________________________________

    Name:
      _______________________________________

    Title:
      ________________________________________

     

     

    ENERGY
      XXI (BERMUDA) LIMITED, as
      Guarantor

     

     

    
      By:
        _________________________________________

      Name:
        _______________________________________

      Title:
        ________________________________________

    

    

     

    ENERGY
      XXI TEXAS, LP,
      as
      Guarantor

    
       

       

      By:
        _________________________________________

      Name:
        _______________________________________

      Title:
        ________________________________________

    

    

     

    ENERGY
      XXI TEXAS GP, LLC,
      as
      Guarantor

    
       

       

      By:
        _________________________________________

      Name:
        _______________________________________

      Title:
        ________________________________________

    

     

     

    ENERGY
      XXI GOM, LLC,
      as
      Guarantor

    
       

       

      By:
        _________________________________________

      Name:
        _______________________________________

      Title:
        ________________________________________

    

     

    
      
        
        

      

      
        27

        
          

        

      

      
        
        

      

    

     

    INITIAL
      PURCHASERS:

     

    JEFFERIES
      & COMPANY, INC. 

     

    By:__________________________

    Name:

    Title:
      

     

     

    GREENWICH
      CAPITAL MARKETS, INC.

     

    By:__________________________

    Name:

    Title:
      

    

    

    BNP
      PARIBAS SECURITIES CORP.

     

    By:__________________________

    Name:

    Title:
      

    

    

    BMO
      CAPITAL MARKETS CORP.

     

    By:__________________________

    Name:

    Title:
      

    

    

    CAPITAL
      ONE SOUTHCOAST, INC.

     

    By:__________________________

    Name:

    Title:
      

     

    
      
        
        

      

      
        28

        
          

        

      

      
        
        

      

    

     

    NATEXIS
      BLEICHROEDER INC.

     

    By:__________________________

    Name:

    Title:

     

    
      
        
        

      

      
        29

        
          

        

      

      
        
        

      

    

    

      	 	 	PURCHASER
	 	 
	 	 	 
	 	 	
              Insert
                name of Purchaser

            
	 	 	 
	 	
              By:

            	 
	 	 	
              Name:

              Title:

            
	 	 	 
	 	Address: 
	 
	 	 	 
	 	 	
            
	 	Telephone: 	 
	 	 	
            
	 	Fax:	 

    

     

    
      
        
        

      

      
        30SECURITIES
      PURCHASE AGREEMENT, dated
      as
      of August 16, 2007 (the “Agreement”),
      among
ONCOVISTA,
      INC., a
      Delaware corporation with offices located at 14785 Omicron Drive, Suite 104,
      San
      Antonio, Texas 78245 (“OncoVista”);
      TORBJÖRN
      B. LUNDQVIST, an
      individual residing at  1001
      Christy Way, Fallbrook, CA 92028 (the
      “Seller”);
      and
      AVIATION
      UPGRADE TECHNOLOGIES, INC., a
      Nevada
      corporation with offices located at 1001 Christy
      Way,
      Fallbrook, CA 92028 (the “Company”).
      

    

    INTRODUCTION

    

    The
      Seller owns beneficially and of record an aggregate of 9,572,300 shares of
      common stock, par value $0.001 per share (the “Common
      Stock”),
      of
      the Company, which includes all shares of Common Stock owned beneficially or
      of
      record thereby, or issuable upon the exercise, conversion, or exchange of
      securities or obligations held by, or owed to, the Seller, which Shares
      represent 83.544% of the outstanding Common Stock at the date hereof. OncoVista
      desires to acquire from the Seller, and the Seller desires to sell to OncoVista,
      9,562,728 of his shares (the “Shares”),
      representing 83.461% of the outstanding Common Stock at the date hereof, in
      accordance with, and subject to, the terms hereof. 

    

    NOW,
      THEREFORE,
      in
      consideration of the premises and mutual representations, warranties and
      covenants herein contained, the parties hereby agree as follows:

    

    ARTICLE
      I

    

    CERTAIN
      DEFINITIONS

    

    “Additional
      Stock Purchase Agreements”
shall
      mean the stock purchase agreements referenced in Schedule B hereto.

    

    “AUT”
shall
      mean Automotive Upgrade Technologies, Inc., a Nevada corporation and a
      wholly-owned subsidiary of the Company.

    

    “AUT
      Products Liability Insurance Policies”
shall
      have the definition assigned thereto in Section 2.02(a)(i)(E).

    

    “Business
      Day”
shall
      mean any day which is not a Saturday or Sunday and is not a day on which banking
      institutions are generally authorized or obligated to close in the City of
      New
      York, New York.

    

    “Closing”
shall
      mean the closing of the purchase by OncoVista from the Seller of the
      Shares.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    “Closing
      Date”
shall
      have the definition assigned thereto in Section 2.03(a) hereof.

    

    “Code”
shall
      have the definition assigned thereto in Section 3.01(d).

    

    “Common
      Stock”
shall
      have the definition assigned thereto in to introduction hereto. 

    

    “Company”
shall
      have the definition assigned thereto in the introductory paragraph
      hereto.

    

    “DGCL”
shall
      mean the Delaware General Corporation Law.

    

    “Dispose
      Of”
shall
      mean to pledge, hypothecate, give away, sell, grant an option (other than
      pursuant hereto) with respect to, or otherwise transfer. 

    

    “Environmental
      Laws” shall
      have the definition assigned thereto in Section 3.01(q).

    

    “ERISA”
shall
      mean the Employee Retirement Income Security Act of 1974, as
      amended.

    

    “Escrow
      Account”
shall
      mean the escrow account established at First Republic Bank pursuant to the
      Escrow Agreement.

    

    “Escrow
      Agreement”
shall
      means the Escrow Agreement, dated as of the date hereof, among the parties
      hereto and Reitler Brown & Rosenblatt LLC, counsel to OncoVista, as escrow
      agent.

     

    “Exchange
      Act”
shall
      have the definition assigned thereto in Section 3.01(a)(i).

    

    “Existing
      Directors”
shall
      have the definition assigned thereto in Section 4.04.

    

    “Investment
      Company Act”
shall
      have the definition assigned thereto in Section 3.01(n).

    

    “Last
      Company Financial Statement Date”
shall
      mean March 31, 2007.

    

    “Last
      Company Financial Statements”
shall
      mean the balance sheet, statement of income, and statement of cash flows, and
      the notes thereto, of the Company as of the Last Company Financial Statement
      Date.

    

    “MAC”
shall
      mean MAC Financial Corp., which has served as special financial adviser in
      connection with the transactions contemplated hereby and in connection
      herewith.

    

    “New
      Directors”
shall
      have the definition assigned thereto in Section 4.04.

    

    “OncoVista”
shall
      have the definition assigned thereto in the introductory paragraph
      hereto.

    

    “Purchase
      Price”
shall
      have the definition assigned thereto in Section 2.01 hereof.

     

    
      
        
        

      

      
        -2-

        
          

        

      

      
        
        

      

    

     

    “Reorganization”
shall
      mean the proposed contribution to the Company by the stockholders of OncoVista
      of all outstanding shares of capital stock of OncoVista in exchange for shares
      of Common Stock, which transactions are referenced in the unanimous consent
      of
      directors of the Company, dated as of August 15, 2007 or any other transaction
      as a result of which OncoVista becomes a wholly-owned subsidiary of the Company
      or merges with the Company. 

    

     “SEC”
shall
      mean the United States Securities and Exchange Commission.

    

    “SEC
      Comments”
shall
      have the definition assigned thereto in Section 2.02(a)(i)(C).

    

    “SEC
      Documents”
shall
      have the definition assigned thereto in Section 3.01(a)(i).

    

    “Securities
      Act”
shall
      mean the Securities Act of 1933, as amended.

    

    “Seller”
shall
      have the definition assigned thereto in the introductory paragraph
      hereto.

    

    “Shares”
shall
      have the definition assigned thereto in the introduction hereto. 

    

    “Taxes”
shall
      have the definitions assigned thereto in Section 3.01(j).

    

    “Ventana”
shall
      mean Ventana Capital Corp., which has served as special financial adviser in
      connection with the transactions contemplated hereby and in connection
      herewith.

    

    ARTICLE
      II

    

    ACQUISITION
      AND EXCHANGE OF SHARES

    

    Section
      2.01   The
      Agreement.
      At
      the
      Closing, OncoVista shall acquire from the Seller, and the Seller shall sell
      to
      OncoVista, the Shares in exchange for an aggregate purchase price of US$667,000
      in cash, less the amount of any liabilities of the Company (the “Purchase
      Price”).
      

    

    Section
      2.02    Closing;
      Exchanges.
      

    

    (a)          
      The
      Closing shall take place on the
      date
      hereof
      (the
“Closing
      Date”)
      at the
      offices of Reitler Brown & Rosenblatt LLC, 800 Third Avenue, 21st
      Floor,
      New York, New York 10022. 

    

    (i)           
      No
      later
      than ten (10) calendar days from the Closing Date, Seller shall:

    

    (A)         
      deliver
      or cause to be delivered to OncoVista
      stock
      certificates evidencing the Shares, registered in the name of OncoVista or
      its
      designee;

    

    (B)          
      provide
      Escrow Agent with written instructions to deliver to Ventana the aggregate
      amount of US$42,000 by certified or official bank check or by electronic wire
      transfer in accordance with instructions theretofore provided by Ventana to
      the
      Seller, as required by Section 4.06 hereof
      and to
      deliver to the selling stockholders named in the Additional 
      
        
          
          

        

        
          -3-

          
            

          

        

        
          
          
Stock
          Purchase Agreements all amounts payable thereto pursuant to such agreement
          by
          the purchasers named therein;

      

    

     

    (C)         
      cause
      the
      Company to file amendments to its 10KSB for the year ended December 31, 2006,
      and for the 10QSB for the quarter ended March 31, 2007, in response to the
      SEC
      comment letters attached as Schedule 3.01(a)(i)
      (the
“SEC
      Comments”);
      

    

    (D)         
      cause
      the
      Company to
      file
      its corporate tax returns for the years ended 2005 and 2006
      and pay
      any taxes and penalties related thereto or arising therefrom;
      

    

    (E)         
      deliver
      to OncoVista evidence that the Company has been added to the products liability
      insurance policies of AUT (the “AUT
      Products Liability Insurance Policies”)
      as an
      additional insured; and

    

    (F)          
      deliver
      to OncoVista evidence that the Seller has complied with Section 4.09
      hereof.

    

    (ii)          
      At
      or
      before the Closing Date, OncoVista shall: 

    

    (A)         
      deliver
      to the Escrow Account the Purchase Price by certified or official bank check
      or
      by electronic wire transfer in accordance with instructions theretofore provided
      by the Seller to OncoVista;

     

    (B)         
      deliver
      to MAC the aggregate amount of US$83,000 by certified or official bank check
      or
      by electronic wire transfer in accordance with instructions theretofore provided
      by MAC to OncoVista, as required by Section 4.05 hereof; and

    

    (C)         
      agree
      to spin
      off AUT
      to
      Seller in exchange for Seller’s agreement to: (i) forgive any related party debt
      owed by the Company to Seller; (ii)
      terminate the Licensing Agreement between the Company and Seller without any
      further consideration from the Company to Seller,
      and
      (iii) indemnify the Company against any products liability relating to the
      business and products of AUT or the business of the Company prior to the
      transactions contemplated hereby;

    

    (iii)         
      At
      or
      before the Closing Date, the Company will deliver to OncoVista an Officer’s
      Certificate in the form of Exhibit
      2.02(a)(iii)
      hereto,
      dated the Closing Date, certifying, among other things, that all
      representations, warranties, covenants, and conditions set forth herein by
      the
      Seller and the Company are true and correct as of, or have been fully performed
      and complied with by, the Closing Date; 

    

    (iv)        
      At
      or
      before the Closing Date, the Seller will deliver to OncoVista and the Company
      a
      certificate in the form of Exhibit
      2.02(a)(iv)
      hereto,
      dated the Closing Date, certifying that all representations, warranties,
      covenants, and conditions set forth herein by the Seller and the Company are
      true and correct as of, or have been fully performed and complied with by,
      the
      Closing Date; 

     

    
      
        
        

      

      
        -4-

        
          

        

      

      
        
        

      

    

     

    (v)          
      At
      or
      before the Closing Date, OncoVista, or a duly appointed agent thereof, will
      deliver to the Seller one or more Certificates in the form of Exhibit
      2.02(a)(v)
      hereto,
      dated the Closing Date, certifying that all representations, warranties,
      covenants and conditions set forth herein by OncoVista are true and correct
      as
      of, or have been fully performed and complied with by, the Closing Date;
      and

    

    (vi)         
      At
      or
      before the Closing Date, the Seller and OncoVista shall execute a cross-receipt
      in the form of Exhibit
      2.02(a)(vi)
      hereto.

    

    (b)          
      The
      Shares shall be authorized, issued, and outstanding shares of Common Stock.
      All
      Shares shall be deemed “restricted
      securities”
as
      defined in paragraph (a) of Rule 144 under the Securities Act. The acquisition
      by OncoVista of the Shares shall be subject to an exemption from the
      registration requirements of the Securities Act, under Section 4(1) of the
      Securities Act and the rules and regulations promulgated thereunder.
      Certificates representing the Shares shall bear a restrictive legend in
      substantially the following form:

    `

    The
      shares represented by this certificate have not been registered under the
      Securities Act of 1933, as amended, and may not be offered for sale, sold,
      or
      otherwise disposed of, except in compliance with the registration provisions
      of
      such Act or pursuant to an exemption from such registration provisions, the
      availability of which is to be established to the satisfaction of the
      Company.

     

    Section
      2.03   Approval.
      In
      anticipation of this Agreement, the Board of Directors of the Company and of
      OncoVista has taken all necessary and requisite corporate and other action
      in
      order to approve this Agreement and all transactions contemplated hereby and
      in
      connection herewith and the Reorganization and the terms thereof.

    

    ARTICLE
      III

    

    REPRESENTATIONS
      AND WARRANTIES

     

    Section
      3.01    Representations
      and Warranties of the Seller and the Company.
      The
      Seller and the Company, jointly and severally, represent and warrant to, and
      agree with, OncoVista as follows:

    

    (a)         
      (i)            
      The
      Common Stock has been registered under Section 12(g) of the Securities Exchange
      Act of 1934, as amended (the “Exchange
      Act”)
      and
      the Company is subject to the periodic reporting requirements of Section 13
      of
      the Exchange Act. The Company has made available to OncoVista true, complete,
      and correct copies of all forms, reports, schedules, statements, and other
      documents required to be filed by it under the Exchange Act, as such documents
      have been amended since the time of the filing thereof (collectively, including
      all forms, reports, schedules, statements, exhibits, and other documents filed
      by the Company therewith, the “SEC
      Documents”).
      Other
      than as disclosed on Schedule 3.01(a)(i), the SEC 
      
        
          
          

        

        
          -5-

          
            

          

        

        
          
          
Documents, including,
          without limitation, any financial statements and schedules included therein,
          at
          the time filed or, if subsequently amended, as so amended, (i) did not
          contain
          any untrue statement of a material fact required to be stated therein or
          necessary in order to make the statements therein not misleading and (ii)
          complied in all respects with the applicable requirements of the Exchange
          Act
          and the applicable rules and regulations thereunder. To the Company’s knowledge,
          each director and executive officer thereof has filed with the SEC on a
          timely
          basis all statements required by Section 16(a) of the Exchange Act and
          the rules
          and regulations thereunder.  

      

    

     

    (ii)          
      The
      Company maintains disclosure controls and procedures required by Rule 13a-15
      or
      15d-15 under the Exchange Act; such controls and procedures are effective to
      ensure that: 

    

    (A)         
      all
      material information concerning the Company is made known on a timely basis
      to
      the individuals responsible for the preparation of the Company’s filings with
      the SEC and other public disclosure documents;

    

    (B)          
      transactions
      are executed in accordance with management’s general or specific
      authorizations;

    

    (C)          
      transactions
      are recorded as necessary to permit preparation of financial statements in
      accordance with generally accepted accounting principles and to maintain asset
      accountability;

    

    (D)         
      access
      to
      assets is permitted only in accordance with management’s general or specific
      authorization; and

    

    (E)         
       the
      recorded accountability for assets is compared with the existing assets at
      reasonable intervals and appropriate action is taken with respect to any
      differences.

    

    The
      Company has made available to OncoVista copies of, all written descriptions
      of,
      and all policies, manuals and other documents promulgating, such disclosure
      controls and procedures.  The books, records and accounts of the Company
      accurately and fairly reflect, in reasonable detail, the transactions in, and
      dispositions of, the assets of, and the results of operations of, the Company
      all to the extent required by generally accepted accounting principles.

    

    (iii)         
      The
      Chief
      Executive Officer and the Chief Financial Officer of the Company have signed,
      and the Company has furnished to the SEC, all certifications required by
      Sections 302 and 906 of the Sarbanes-Oxley Act of 2002; such certifications
      contain no qualifications or exceptions to the matters certified therein and
      have not been modified or withdrawn; and neither the Company nor any of its
      officers has received notice from any governmental entity questioning or
      challenging the accuracy, completeness, form or manner of filing or submission
      of such certifications. 

    

    (iv)         
      The
      Company has heretofore has provided to OncoVista complete and correct copies
      of
      all certifications filed with the SEC pursuant to Sections 302 and 906 of

       

      
        
          
          

        

        
          -6-

          
            

          

        

        
          
          
Sarbanes-Oxley Act of 2002
          and hereby reaffirms, represents and warrants to OncoVista the matters
          and
          statements made in such certificates.

      

    

     

    
      
        (b)          
          At
          the
          date hereof and at the Closing Date:

      

    

    

    (i)           
      the
      Common Stock is eligible to trade and be quoted on, and is quoted on, the
      over-the-counter Bulletin Board market maintained by The Nasdaq Stock Market
      (the “OTCBB”)
      and
      has received no notice or other communication indicating that such eligibility
      is subject to challenge or review by the any applicable regulatory agency,
      electronic market administrator, or exchange; 

    

    (ii)         
       the
      Company has and shall have performed or satisfied all of its undertakings to,
      and of its obligations and requirements with, the SEC; and

    

    (iii)         
      the
      Company has not, and shall not have taken any action that would preclude, or
      otherwise jeopardize, the inclusion of the Common Stock for quotation on the
      OTCBB.

    

    (c)         
       Other
      than as disclosed on Schedule 3.01(a)(i), the Company has no subsidiaries or
      affiliated corporation or owns any interest in any other enterprise (whether
      or
      not such enterprise is a corporation). The
      Company has been duly organized and is validly existing as a corporation in
      good
      standing under the laws of the State
      of
      Nevada with
      full
      power and authority (corporate and other) to own, lease and operate its
respective
      properties
      and conduct its respective
      business
      as described in the SEC Documents;
      except
      as otherwise disclosed on Schedule 3.01(c), the
      Company is duly qualified to do business as a foreign corporation and is in
      good
      standing in each jurisdiction in which the ownership or leasing of its
      properties or the conduct of its business requires such qualification, except
      where the failure to be so qualified or be in good standing would not have
      a
      material adverse effect on its business,
      prospects, condition
      (financial or otherwise), and results of operations of the Company; no
      proceeding has been instituted in any such jurisdiction, revoking, limiting
      or
      curtailing, or seeking to revoke, limit or curtail, such power and authority
      or
      qualification; the Company is in possession of,
      and
      operating in compliance with,
      all
      authorizations, licenses, certificates, consents, orders and permits from state,
      federal,
      foreign
      and
      other regulatory authorities that are material to the conduct of its business,
      all of which are valid and in full force and effect; the Company is not
      in
      violation of its charter or bylaws or in default in the performance or
      observance of any obligation, agreement, covenant or condition contained in
      any
      material bond, debenture, note or other evidence of indebtedness, or in any
      material lease, contract, indenture, mortgage, deed of trust, loan agreement,
      joint venture or other agreement or instrument to which it is a party or by
      which it or its properties or assets may be bound,
      which
      violation or default would have a material adverse effect on the business,
      prospects, financial condition or results of operations of the
      Company;
      and the
      Company is not
      in
      violation of any law, order, rule, regulation, writ, injunction, judgment or
      decree of any court, government or governmental agency or body, domestic or
      foreign, having jurisdiction over the Company or over its properties or
      assets,
      which
      violation would have a material adverse effect on the business, prospects,
      financial condition or results of operations of the Company taken as a
      whole.
      The SEC

      
        
        

      

      
        -7-

        
          

        

      

      
        
        
Documents accurately
        describe any corporation, association or other entity owned or controlled,
        directly or indirectly, by the Company.

    

     

    (d)         
       (i)          
      Each
      of
      the Seller and the Company has all requisite power and authority to execute,
      deliver, and perform this Agreement and the Escrow Agreement. All necessary
      proceedings of the Company have been duly taken to authorize the execution,
      delivery, and performance of this Agreement and the Escrow Agreement thereby.
      Each of this Agreement and the Escrow Agreement has been duly authorized,
      executed, and delivered by the Seller and the Company, constitutes the legal,
      valid, and binding obligation of each of the Seller and the Company, and is
      enforceable as to the Seller and the Company in accordance with its respective
      terms. Except as otherwise set forth in this Agreement, no consent,
      authorization, approval, order, license, certificate, or permit of or from,
      or
      declaration or filing with, any federal, state, local, or other governmental
      authority or any court or other tribunal is required by the any Seller or the
      Company for the execution, delivery, or performance of this Agreement or the
      Escrow Agreement thereby. No
      consent, approval, authorization or order of,
      or
      qualification with,
      any
      court, government or governmental agency or body, domestic or foreign, having
      jurisdiction over the Seller
      or
      the Company
      or over its respective
      properties
      or assets is required for the execution and delivery of this Agreement
or
      the
      Escrow Agreement and
      the
      consummation by the
      Seller and the
      Company of the transactions herein and
      therein contemplated,
      except such as may be required under the Securities
      Act
      or
      under state or other securities or blue
      sky
      laws,
      all of which requirements have been,
      or in
      accordance therewith will be,
      satisfied in all material respects.
      No
      consent of any party to any material contract, agreement, instrument, lease,
      license, arrangement, or understanding to which the Seller or the Company is
      a
      party, or to which its or any of its respective businesses, properties, or
      assets are subject, is required for the execution, delivery, or performance
      of
      this Agreement or the Escrow Agreement; and the execution, delivery, and
      performance of this Agreement and the Escrow Agreement will not violate, result
      in a breach of, conflict with, or (with or without the giving of notice or
      the
      passage of time or both) entitle any party to terminate or call a default under,
      entitle any party to receive rights or privileges that such party was not
      entitled to receive immediately before this Agreement was executed under, or
      create any obligation on the part of the Seller or the Company to which it
      was
      not subject immediately before this Agreement or the Escrow Agreement was
      executed under, any term of any such material contract, agreement, instrument,
      lease, license, arrangement, or understanding, or violate or result in a breach
      of any term of the certificate of incorporation or by-laws of the Company or
      (if
      the provisions of this Agreement are satisfied) violate, result in a breach
      of,
      or conflict with any law, rule, regulation, order, judgment, decree, injunction,
      or writ of
      any
      court, government or governmental agency or body, domestic or foreign, having
      jurisdiction over the Seller
      or
      the Company
      or over its respective
      properties
      or assets.

    

    (ii)           
      The
      Seller is an individual who has reached the age majority in his state of
      residence. 

    

    (e)          
      There
      is
      not any pending or, to the best of Seller’s
      and the Company's
      knowledge, threatened, action, suit, claim or proceeding against the
Seller
      or
      the Company,
      or any of the Company’s
      officers
      or any of the respective properties, assets or rights
      of the
      Seller or of the Company,
      before
      any court, government or governmental agency or body, domestic or foreign,
      
      
        
        

      

      
        -8-

        
          

        

      

      
        
        

      

       

      having
        jurisdiction over the Seller
        or
        the Company
        or over the Company’s
        officers
        or the
        properties
        of
        the
        Seller or the Company, or
        otherwise that (i) is reasonably likely to result in any material adverse
        change
        in the respective
        business, prospects, financial condition
        or results of operations of the
        Seller or the
        Company or might materially and adversely affect their properties, assets
        or
        rights taken
        as
        a whole, (ii)
        might prevent consummation of the transactions contemplated by this Agreement,
        or
        (iii)
        alleging
        violation of any Federal or state securities laws.

    

     

    (f)           
      The
      authorized capital stock of the Company consists of 100,000,000 shares of Common
      Stock, of which 11,457,750 shares of Common Stock are outstanding, and 5,000,000
      shares of “blank check” preferred stock, par value $0.001 per share, no shares
      of which are outstanding. Each of such outstanding shares of Common Stock is
      duly and validly authorized, validly issued, fully paid, and nonassessable,
      has
      not been issued and is not owned or held in violation of any preemptive or
      similar right of stockholders. Except as disclosed in the SEC Documents, (i)
      there is no commitment, plan, or arrangement to issue, and no outstanding
      option, warrant, or other right calling for the issuance of, any share of
      capital stock of, or any security or other instrument convertible into,
      exercisable for, or exchangeable for capital stock of, the Company, and (ii)
      except as described in the SEC Documents, there is outstanding no security
      or
      other instrument convertible into or exchangeable for capital stock of the
      Company. When
      delivered by the Seller against payment therefor in accordance with the terms
      of
      this Agreement, the
      Shares will
      be
      duly and validly issued and fully paid and nonassessable, and will be sold
      free
      and clear of any pledge, lien, security interest, encumbrance, claim or
      equitable interest
      of any
      kind;
      and no
      preemptive or
      similar right,
      co-sale right, registration right, right of first refusal or other similar
      right
      of stockholders exists with respect to any of the Shares or the issuance and
      sale thereof other than those that have been expressly waived prior to the
      date
      hereof and those that will automatically expire upon the execution hereof.
      No
      further approval or authorization of any stockholder, the Board of Directors
      of
      the Company or others is required for the issuance and sale or transfer of
      the
      Shares,
      except
      as may be required under the Securities Act, the rules
      and
regulations
      promulgated
      thereunder or
      under
      state or other securities or blue
      sky
      laws.
      The description of the Company's stock option, stock bonus and other stock
      plans
      or arrangements, and the options or other rights granted and exercised
      thereunder, set forth in the SEC Documents accurately and fairly presents the
      information required to be shown with respect to such plans, arrangements,
      options and rights under the Securities Act,
      the
      Exchange Act,
      and the
rules
      and
regulations
      promulgated thereunder.
       Schedule
      3.01(f)
      hereto
      sets forth the options and warrants and convertible and exchangeable securities
      of the Company outstanding at the date hereof, the exercise, conversion, or
      exchange prices thereof, and expiration, termination, or maturity dates
      thereof.

     

    (g)           Stan
      J.H.
      Lee, CPA examined
      the financial statements of the Company, together with the related schedules
      and
      notes, for
      the
      period from January 1, 2006 through December 31, 2006, and
      Armando C. Ibarra, CPA examined
      the financial statements of the Company, together with the related schedules
      and
      notes, for
      the
      period from January 1, 2005 through December 31, 2005 (collectively,
      the “Auditors”),
      filed
      with the SEC as a part of the SEC Documents, are independent accountants within
      the meaning of the Securities Act,
      the
      Exchange Act,
      and the
rules
      and
regulations
      promulgated thereunder;
      and
      except as disclosed in Schedule 3.01(a)(i),
      the
      audited financial statements of the Company, together with the related schedules
      and notes, and the unaudited financial information, forming part of the SEC
      Documents, fairly present and
      will
      fairly 
      
        
          
          

        

        
          -9-

          
            

          

        

        
          
          

        

      

    

     present
      the
      financial position and the results of operations of the Company at the
      respective dates and for the respective periods to which they apply; and all
      audited financial statements of the Company, together with the related schedules
      and notes, and the unaudited financial information, filed with the SEC as part
      of the SEC Documents, complied
      and will comply as to form in all material respects with applicable accounting
      requirements and with the rules and regulations of the SEC with respect hereto
      when filed, have
      been
and
      will
      be prepared
      in accordance with generally accepted accounting principles consistently applied
      throughout the periods involved except as may be otherwise stated
      therein
      (except
      as may be indicated in the notes thereto or as permitted by the rules and
      regulations of the SEC) and fairly present and will fairly present, subject
      in
      the case of the unaudited financial statements, to customary year end audit
      adjustments, the financial position of the Company as at the dates thereof
      and
      the results of its operations and cash flows. The
      procedures pursuant to which the aforementioned financial statements have been
      audited are compliant with generally accepted auditing standards. The
      selected and summary financial and statistical data included in the SEC
      Documents present and
      will
      present fairly
      the information shown therein and have been compiled on a basis consistent
      with
      the audited financial statements presented therein. No other financial
      statements or schedules are required to be included in the SEC
      Documents.
      The
      financial statements referred to in this Section 3.01(g) contain all
      certifications and statements required under the SEC’s Order, dated June 27,
      2002, pursuant to Section 21(a)(1) of the Exchange Act (File No. 4-460), Rule
      13a-14 or 15d-14 under the Exchange Act, or 18 U.S.C. Section 1350 (Sections
      302
      and 906 of the Sarbanes-Oxley Act of 2002) with respect to the report relating
      thereto. Since the Last Company Financial Statement Date:

     

    (i)           
      There
      has
      at no time been a material adverse change in the financial condition, results
      of
      operations, businesses, properties, assets, liabilities, or future prospects
      of
      the Company;

    

    (ii)          
      The
      Company has not authorized, declared, paid, or effected any dividend or
      liquidating or other distribution in respect of its capital stock or any direct
      or indirect redemption, purchase, or other acquisition of any stock of the
      Company.

     

    (iii)         
      Except
      as
      set forth in the SEC Documents, the operations and businesses of the Company
      have been conducted in all respects only in the ordinary course.

     

    There
      is
      no fact known to the Company which materially adversely affects or in the future
      (as far as the Company can reasonably foresee) may materially adversely affect
      the financial condition, results of operations, businesses, properties, assets,
      liabilities, or future prospects of the Company; provided, however, that the
      Company expresses no opinion as to political or economic matters of general
      applicability. The Company has made known, or caused to be made known, to the
      accountants or auditors who have prepared, reviewed, or audited the
      aforementioned consolidated financial statements all material facts and
      circumstances which could affect the preparation, presentation, accuracy, or
      completeness thereof.

    

    (h)          
      Subsequent
      to the respective dates as of which information is given in the SEC Documents,
      there has not been (i) any material adverse change in the business,
      prospects, financial condition
      or results of operations of the Company, (ii) any transaction
      committed to or 
      
        
          
          

        

        
          -10-

          
            

          

        

        
          
          
consummated
          that is
          material to the Company, (iii) any obligation, direct or contingent, that
          is
          material to the Company incurred
          by the Company, except such
          obligations
          as
          have
          been incurred
          in the ordinary course of business, (iv) any change in the capital stock
          or
          outstanding indebtedness of the Company or
          Subsidiary that
          is
          material to the Company, (v) any dividend or distribution of any kind declared,
          paid,
          or made
          on the capital stock of the Company, or (vi) any loss or damage (whether
          or not
          insured) to the property of the Company which has a material adverse effect
          on
          the business,
          prospects, condition
          (financial or otherwise), or results of operations thereof.

      

    

     

    (i)            
      At
      the
      Closing, the Company shall have no
      properties or assets
      and the
      Company shall be free
      and
      clear of any pledge, lien, security interest, encumbrance, claim or equitable
      interest.
      At the
      Closing, the Company shall be party to no agreements except for this Agreement
      and the Additional Stock Purchase Agreements, each of which shall be
legal,
      valid
      and
      binding agreements,
      enforceable against the Company in accordance with their respective
      terms.
      Set
      forth
      as Schedule 3.01(i) hereto is a true and correct list of the selling
      stockholders named in the Additional Stock Purchase Agreements, as well as
      the
      shares of Common Stock to be sold thereby pursuant to such Additional Stock
      Purchase Agreements. Each Additional Stock Purchase Agreement is a legal, valid
      and binding agreement, enforceable against the selling stockholder named therein
      in accordance with its respective terms.

    

    (j)           
      Other
      than related party liabilities,
      all of
      which are owed to Seller and affiliates thereof,
      the
      Company’s liabilities, in the aggregate, are less than the Purchase Price (less
      the amount payable hereunder to Ventana). All such liabilities, other than
      those
      to related parties, shall be paid at Closing from the Escrow. At or before
      the
      Closing, all related party liabilities shall be forgiven or otherwise
      extinguished. Other than as disclosed in Schedule 3.01(j), the Company has
      no
      liability of any nature, accrued or contingent, including, without limitation,
      liabilities for federal, state, local, or foreign taxes and penalties, interest,
      and additions to tax (“Taxes”),
      and
      liabilities to customers or suppliers. Without limiting the generality of the
      foregoing, the amounts set up as provisions for Taxes, if any, in the Last
      Company Financial Statements are sufficient for all accrued and unpaid Taxes
      of
      the Company, whether or not due and payable and whether or not disputed, under
      tax laws, as in effect on the Last Company Financial Statement Date or now
      in
      effect, for the period ended on such date and for all fiscal periods prior
      thereto. The execution, delivery, and performance of this Agreement by the
      Company will not cause any Taxes to be payable (other than those that may
      possibly be payable by the Seller as a result of the sale of the Shares) or
      cause any lien, charge, or encumbrance to secure any Taxes to be created either
      immediately or upon the nonpayment of any Taxes other than on the properties
      or
      assets of the Sellers. The Internal Revenue Service has audited and settled
      or
      the statute of limitations has run upon all federal income tax returns of the
      Company and each Seller for all taxable years up to and including the taxable
      year ended December 31, 2000. The Company has filed all federal, state, local,
      and foreign tax returns required to be filed by it; has made available to
      OncoVista a true and correct copy of each such return which was filed in the
      past six years; has paid (or has established on the last balance sheet included
      in the last Company Financial Statement a reserve for) all Taxes, assessments,
      and other governmental charges payable or remittable by it or levied upon it
      or
      its properties, assets, income, or franchises which are due and payable; and
      has
      delivered to OncoVista a true and correct copy of any report as to adjustments
      received by it from any taxing authority during the past six years and a
      statement as to any litigation, governmental or other 
      
        
        

      

      
        -11-

        
          

        

      

      
        
        
proceeding (formal or
        informal), or investigation pending, threatened, or in prospect with respect
        to
        any such report or the subject matter of such report. Each Seller has paid
        all
        taxes payable thereby due on or prior to the date hereof.

    

     

    (k)          
      Except
      as
      disclosed in Schedule 3.01(k), the
      Company does
      not
      have any
      insurance;
      the
      Company has at
      no
      time been
      refused any insurance coverage sought or applied for.

    

    (l)          
       (i)          
      No
      labor
      disturbance by the employees of the Company exists or, to the best of the
      Company’s knowledge, is imminent. The Company is not aware of any existing or
      imminent labor disturbance by the employees of any principal suppliers or
      customers of
      the
      Company that
      might be expected to result in any material adverse change in the business,
      prospects, financial condition,
      or results of operations of the Company. No collective bargaining agreement
      exists with any of the Company’s
      employees and, to the best of each Seller’s
      and the Company's
      knowledge, no such agreement is imminent.

    

    (ii)          
      The
      Company does not have, or contribute to, and has never maintained or contributed
      to, any pension, profit-sharing, option, other incentive plan, or any other
      type
      of Employee Benefit Plan (as defined in Section 3(3) of ERISA) or Pension Plan
      (as defined in ERISA) and the Company does not have any obligation to or
      customary arrangement with employees for bonuses, incentive compensation,
      vacations, severance pay, sick pay, sick leave, insurance, service award,
      relocation, disability, tuition refund, or other benefits, whether oral or
      written. 

     

    (m)         
      The
      Company
      owns or possesses
      the
      right to use
      all
      patents, patent rights, inventions, trade secrets, know-how, trademarks, service
      marks, trade names,
      logos,
      and
      copyrights described or referred to in the SEC Documents as owned by or used
      by
      it or that are necessary to conduct its respective
      businesses
      as described in the SEC Documents; the Company has not
      received
      any notice of, or has knowledge of, any infringement of or conflict with
      asserted rights of the Company by others with respect to any patents, patent
      rights, inventions, trade secrets, know-how, trademarks, service marks, trade
      names,
      logos,
      or
      copyrights described or referred to in the SEC Documents as owned by or used
      by
      it; and the Company has not
      received
      any notice of, or has no
      knowledge
      of, any infringement of,
      or
      conflict with,
      asserted
      rights of others with respect to any patents, patent rights, inventions, trade
      secrets, know-how, trademarks, service marks, trade names,
      logos,
      or
      copyrights described or referred to in the SEC Documents as owned by or used
      by
      it or which, individually or in the aggregate, in the event of an unfavorable
      decision, ruling or finding, would have a material adverse effect on the
business,
      prospects, financial condition
      or results of operations of the Company. 

    

    (n)          
      The
      Company has been advised concerning the Investment Company Act of 1940, as
      amended (the “Investment
      Company Act”),
      and
      the rules and regulations thereunder, and has in the past conducted, and intends
      in the future,
      to
      conduct its affairs in such a manner as to ensure that it is not and will not
      become an “investment
      company”
      or a
      company “controlled”
      by an “investment company”
      within
      the meaning of the Investment Company Act and such rules and regulations.

     

    
      
        
        

      

      
        -12-

        
          

        

      

      
        
        

      

    

     

    (o)          (i)            
      The
      Company
      has
      not, and
      no person or entity acting on behalf or at the request of the Company
      has,at
      any
      time during the last five years (i) made any unlawful contribution to any
      candidate for foreign office or failed to disclose fully any contribution in
      violation of law, or (ii) made any payment to any federal or state governmental
      officer or official, or other person charged with similar public or quasi-public
      duties, other than payments required or permitted by the laws of the United
      States or any other applicable jurisdiction.

    

    (ii)           Neither
      Company, nor, to the best knowledge of the Seller nor the Company, any director,
      officer, agent, employee, or other person associated with, or acting on behalf
      of, the Company, has, directly or indirectly: used any corporate funds for
      unlawful contributions, gifts, entertainment, or other unlawful expenses
      relating to political activity; made any unlawful payment to foreign or domestic
      government officials or employees or to foreign or domestic political parties
      or
      campaigns from corporate funds; violated any provision of the Foreign Corrupt
      Practices Act of 1977, as amended; or made any bribe, rebate, payoff, influence
      payment, kickback, or other unlawful payment. The Company's internal accounting
      controls and procedures are sufficient to cause the Company to comply in all
      respects with the Foreign Corrupt Practices Act of 1977, as
      amended.

    

    (iii)         
      Neither
      the Seller or the Company, nor any officer, director or affiliate of the
      Company, has been, within the five years ending on the Closing Date, a party
      to
      any bankruptcy petition against such person or against any business of which
      such person was affiliated; convicted in a criminal proceeding or subject to
      a
      pending criminal proceeding (excluding traffic violations and other minor
      offenses); subject to any order, judgment or decree, not subsequently reversed,
      suspended or vacated, of any court of competent jurisdiction, permanently or
      temporarily enjoining, barring, suspending or otherwise limiting their
      involvement in any type of business, securities or banking activities; or found
      by a court of competent jurisdiction in a civil action, by the SEC or the
      Commodity Futures Trading Commission to have violated a federal or state
      securities or commodities law, and the judgment has not been reversed, suspended
      or vacated.

    

    (p)          
      The
      Company
      has not,
      and no person acting on behalf thereof, has
      taken
      or will take, directly or indirectly, any action designed to,
      or that
      might reasonably be expected to cause or result in,
      stabilization in violation of law,
      or
      manipulation,
      of the
      price of the Common Stock to facilitate the sale or resale of the
      Shares.

    

    (q)          
      Except
      as
      set forth in the SEC Documents, (i) the Company is in compliance in
      all
      material respects with
      all
      rules, laws and regulations relating to the use, treatment, storage and disposal
      of toxic substances and protection of health or the environment (“Environmental
      Laws”)
      that
      are applicable to its business, (ii) the Company has not
      received
      notice from any governmental authority or third party of an asserted claim
      under
      Environmental Laws, which claim is required to be disclosed in the SEC
      Documents, (iii) to the best knowledge
      of the
      Company,
      the
      Company is not
      likely
      to
      be required to make future material capital expenditures to comply with
      Environmental Laws (iv) no property which is owned, leased or occupied by the
      Company has been designated as a Superfund site pursuant to the Comprehensive
      Response, Compensation, and Liability Act of 1980, as amended (42 U.S.C.
§
      9601,
et seq.),
      or
      otherwise designated as a 
      
        
          
          

        

        
          -13-

          
            

          

        

        
          
          
contaminated site under
          applicable state or local law, and (v) the Company is  not
          in
          violation of any federal or state law or regulation relating to occupational
          safety or health.

      

    

     

    (r)           
      There
      are
      no outstanding loans, advances or guarantees of indebtedness by the Company
      to,
      or for
      the benefit of,
      any of
      the officers, directors,or
      director-nominees of the Company or any of the members of the families of any
      of
      them, except as disclosed in the SEC Documents. 

    

    (s)          
      The
      Company has not
      incurred
      any liability, direct or indirect, for finders' or similar fees on behalf of
      or
      payable by the Company or OncoVista in connection with the Transaction
      Agreements or any other transaction involving the Company and
      OncoVista,
      except
      as otherwise disclosed herein.

    

    (t)            No
      stockholder of the Company has any right to request or require the Company
      to
      register the sale of any shares owned by such stockholder under the Securities
      Act on any registration statement.

    

    (u)          
      The
      Company is in compliance with, and is not in violation of, applicable federal,
      state, local or foreign statutes, laws and regulations (including without
      limitation, any applicable building, zoning or other law, ordinance or
      regulation) affecting its properties or the operation of its business,
      including, without limitation, Sarbanes-Oxley Act of 2002 and the rules and
      regulations promulgated pursuant thereto or thereunder. The Company is not
      subject to any order, decree, judgment or other sanction of any court,
      administrative agency or other tribunal.

    

    (v)        
       (i)            
      The
      Shares are owned of record and beneficially held by the Seller free and clear
      of
      any security interest, pledge, mortgage, lien (including, without limitation,
      environmental and tax liens), charge, encumbrance, adverse claim, preferential
      arrangement or restriction of any kind, including, without limitation, any
      restriction on the use, voting, transfer (except as otherwise provided herein),
      receipt of income or other exercise of any attributes of ownership. The Shares
      are not subject to any options, warrants, convertible securities or other
      rights, agreements, arrangements or commitments of any character relating to
      interests therein. There are no voting trusts, member agreements, proxies,
      or
      other agreements or understandings in effect with respect to the voting or
      transfer of any of the Shares. Other than the Shares, the Seller owns
      beneficially or of record, no shares of capital stock or other securities of
      the
      Company, and do not own beneficially or of record, any securities exercisable
      for, or convertible into or exchangeable for, securities of the
      Company.

    

    (ii)            The
      Seller acquired the Shares from the Company in private transactions not
      involving a public offering and, on the dates of such acquisitions, the Seller
      paid the full purchase price therefor. The Shares are “restricted
      securities”
as
      defined in Rule 144(a) under the Securities Act.

     

    
      
        
        

      

      
        -14-

        
          

        

      

      
        
        

      

    

     

    (iii)         
      Neither
      the Seller nor any affiliate thereof knows of any material adverse information
      regarding the current or prospective operations of the Company which has not
      been publicly disclosed. 

    

    (w)          
      All
      brochures, product information, business cards, etc. and operations are done
      through the Company’s subsidiary, AUT.
      However, the bank account and billing is done through the Company. 

    

    Section
      3.02    Representations
      and Warranties of OncoVista.
      OncoVista hereby represents and warrants to, and agrees with,
      Seller:

    

    (a)          
      OncoVista
      has all requisite power and authority to execute, deliver, and perform this
      Agreement and the Escrow Agreement. All necessary proceedings of OncoVista
      have
      been duly taken to authorize the execution, delivery, and performance of this
      Agreement and the Escrow Agreement thereby. Each of this Agreement and the
      Escrow Agreement has been duly authorized, executed, and delivered by OncoVista,
      constitutes the legal, valid, and binding obligation of OncoVista, and is
      enforceable as to OncoVista in accordance with its respective terms. Except
      as
      otherwise set forth in this Agreement, no consent, authorization, approval,
      order, license, certificate, or permit of or from, or declaration or filing
      with, any federal, state, local, or other governmental authority or any court
      or
      other tribunal is required by OncoVista for the execution, delivery, or
      performance of this Agreement or the Escrow Agreement thereby. No
      consent, approval, authorization or order of,
      or
      qualification with,
      any
      court, government or governmental agency or body, domestic or foreign, having
      jurisdiction over OncoVista or
      over
      its respective
      properties
      or assets is required for the execution and delivery of this Agreement
and
      the
      Escrow Agreement and
      the
      consummation by OncoVista
      of
      the
      transactions herein contemplated, except such as may be required under the
      Securities
      Act
      or
      under state or other securities or blue
      sky
      laws,
      all of which requirements have been,
      or in
      accordance therewith will be,
      satisfied in all material respects.
      No
      consent of any party to any material contract, agreement, instrument, lease,
      license, arrangement, or understanding to which OncoVista is a party, or to
      which its or any of its businesses, properties, or assets are subject, is
      required for the execution, delivery, or performance of this Agreement and
      the
      Escrow Agreement; and the execution, delivery, and performance of this Agreement
      and the Escrow Agreement will not violate, result in a breach of, conflict
      with,
      or (with or without the giving of notice or the passage of time or both) entitle
      any party to terminate or call a default under, entitle any party to receive
      rights or privileges that such party was not entitled to receive immediately
      before this Agreement or the Escrow Agreement was executed under, or create
      any
      obligation on the part of OncoVista to which it was not subject immediately
      before this Agreement or the Escrow Agreement was executed under, any term
      of
      any such material contract, agreement, instrument, lease, license, arrangement,
      or understanding, or violate or result in a breach of any term of the operating
      agreement of the Company or (if the provisions of this Agreement are satisfied)
      violate, result in a breach of, or conflict with any law, rule, regulation,
      order, judgment, decree, injunction, or writ of
      any
      court, government or governmental agency or body, domestic or foreign, having
      jurisdiction over OncoVista or over its properties or assets.

    

    (b)          
      OncoVista
      is an “accredited
      investor”
as
      defined in Rule 501 of Regulation D under the Securities Act. OncoVista is
      acquiring the Shares for its own account (and not for the account 
      
        
          
          

        

        
          -15-

          
            

          

        

        
          
          

        

      

    

    of
      others) for investment and not with a view to the distribution or resale thereof
      in violation of the Securities Act. OncoVista understands that it may not sell
      or otherwise Dispose Of
      such
      Shares in the absence of either an effective registration statement under the
      Securities Act or an exemption from the registration provisions of the
      Securities Act. OncoVista acknowledges being informed that the shares of Common
      Stock acquired thereby shall be unregistered, shall be “restricted
      securities”
as
      defined in Rule 144(a) under the Securities Act, and must be held indefinitely
      unless (i) they are subsequently registered under the Securities Act, or
      (ii) an exemption from such registration is available. OncoVista further
      acknowledges that the Company does not have an obligation to currently register
      such securities for the account of OncoVista. 

     

    (c)          
      By
      virtue
      of OncoVista’s position, it has access to the same kind of information which
      would be available in a registration statement filed under the Securities Act.
      OncoVista acknowledges that it has been afforded access to all material
      information which it has requested relevant to its decision to acquire the
      Shares to acquired thereby and to ask questions of the Company’s management and
      that, except as set forth herein, neither Seller or the Company nor anyone
      acting on behalf of the Seller or the Company, has made any representations
      or
      warranties to OncoVista which have induced, persuaded, or stimulated OncoVista
      to acquire such Shares. 

     

    (d)          
      Either
      alone, or together with their investment advisor(s), OncoVista has the knowledge
      and experience in financial and business matters to be capable of evaluating
      the
      merits and risks of the prospective investment in the Shares to be acquired
      thereby, and OncoVista is and will be able to bear the economic risk of the
      investment in such Shares. 

     

    (e)           
      The
      information contained in OncoVista’s private placement memorandum dated
July
      25,
      2007, as amended by Supplement No. 1 thereto, dated July 30,
      2007
      (the “PPM”)
      and
      attached hereto as Exhibit 3.02(e), is completely accurate in all material
      respects and does not contain or omit any information that would make the
      information contained therein misleading in any material respects. Since
July 25,
      2007:

     

    (i)            
      There
      has
      at no time been a material adverse change in the financial condition, results
      of
      operations, businesses, properties, assets, liabilities, or future prospects
      of
      OncoVista;

     

    (ii)          
      OncoVista
      has not authorized, declared, paid, or effected any dividend or liquidating
      or
      other distribution in respect of its capital stock or any direct or indirect
      redemption, purchase, or other acquisition of any stock of OncoVista;
      and

     

    (iii)         
      Except
      as
      set forth in the PPM, the operations and businesses of OncoVista have been
      conducted in all respects only in the ordinary course.

     

    There
      is
      no fact known to OncoVista which materially adversely affects or in the future
      (as far as OncoVista can reasonably foresee) may materially adversely affect
      the
      financial condition, results of operations, businesses, properties, assets,
      liabilities, or future prospects of OncoVista; provided, however, that OncoVista
      expresses no opinion as to political or economic matters of general
      applicability. OncoVista has made known, or caused to be made known, to the
      accountants or auditors who have prepared, reviewed, or audited the
      aforementioned consolidated financial statements all material facts and
      circumstances which could affect the preparation, presentation, accuracy, or
      completeness thereof.

     

    
      
        
        

      

      
        -16-

        
          

        

      

      
        
        

      

    

     

    (f)           
      Subsequent
      to July
      25,
      2007, except relating to the transactions contemplated hereby, there
      has
      not been (i) any material adverse change in the business,
      prospects, financial condition
      or results of operations of OncoVista, (ii) any transaction
      committed to or consummated
      that is
      material to OncoVista,
      (iii)
      any obligation, direct or contingent, that is material to OncoVista
      incurred
      by OncoVista,
      except
such
      obligations
      as
      have
      been incurred
      in the ordinary course of business, (iv) any change in the outstanding
      indebtedness of OncoVista
      that
      is
      material to OncoVista,
      (v) any
      dividend or distribution of any kind declared, paid,
      or made
      on the capital stock of OncoVista, or (vi) any loss or damage (whether or not
      insured) to the property of OncoVista
      which
      has a material adverse effect on the business,
      prospects, condition
      (financial or otherwise), or results of operations thereof.

    

    ARTICLE
      IV

    

    ADDITIONAL
      COVENANTS

    

    Section
      4.01   Indemnity.
      The
      Seller agrees
      to
      indemnify and hold harmless OncoVista and its officers, directors, employees,
      counsel, agents, and stockholders, in each case past, present, or as they may
      exist at any time after the date of this Agreement, and each person, if any,
      who
      controls, controlled, or will control any of them within the meaning of Section
      15 of the Securities Act or Section 20(a) of the Securities Exchange Act of
      1934, as amended, against any and all losses, liabilities, damages, and expenses
      whatsoever (which shall include, for all purposes of this Article IV, but not
      be
      limited to, counsel fees and any and all expenses whatsoever incurred in
      investigating, preparing, or defending against any litigation, commenced or
      threatened, or any claim whatsoever, and any and all amounts paid in settlement
      of any claim or litigation) as and when incurred arising out of, based upon,
      or
      in connection with (a) any material breach of any representation, warranty,
      covenant, or agreement of the Seller or the Company contained in this
      Agreement,
      (b) if
      the Closing takes place, any act
      or
alleged
      omission
      occurring at or prior to the Closing (including without limitation any which
      arise out of, are based upon, or are in connection with any of the transactions
      contemplated hereby) which subjects OncoVista to damages related
      to the intentional act or intentional omission,
      (c) the
      SEC Comments, (d) the products of AUT or the Company, if any, and (e) any claim
      arising out of the transactions contemplated by the Additional Stock Purchase
      Agreements.
      The
      foregoing agreement to indemnify shall be in addition to any liability Seller,
      the Company or AUT
      may
      otherwise have, including liabilities arising under this Agreement.

     

    Section
      4.02   Stockholders;
      Other Securities.
      The
      Seller hereby agrees that immediately prior to the Closing, the Company will
      have at least 100 stockholders. Prior to the date of this Agreement, all of
      the
      Company’s outstanding convertible debt, options, warrants and all other
      indebtedness of the Company shall have been converted to shares of Common Stock.
      

    

    Section
      4.03    Assets
      and Liabilities.
      At
      the
      Closing, the Company shall have no assets and no liabilities. 

    

    Section
      4.04   Corporate
      Governance.
      At
      the
      Closing, (a) the Board of Directors of the 
      
        
        

      

      
        -17-

        
          

        

      

      
        
        
Company shall consist of one
        current  director
        (the
“Existing
        Director”),
        who
        shall resign immediately thereafter,
        and two
        directors appointed by OncoVista (the “New
        Directors”),
        and
        (b) all officers of the Company shall resign and the Board of Directors shall
        appoint the designees of OncoVista as the sole officers thereof. 

    

     

    Section
      4.05   Payment
      to MAC.
      At
      the
      Closing, OncoVista shall pay to, or as directed by MAC, the sum of $83,000.
      MAC
      shall be entitled to enforce the covenant set forth in this Section 4.05 against
      OncoVista only.

    

    Section
      4.06   Payment
      to Ventana.
      At
      the
      Closing, the Seller shall pay to, or as directed by Ventana, the sum of $42,000.
      Ventana shall be entitled to enforce the covenant set forth in this Section
      4.06
      as against Seller only.

    

    Section
      4.07   Insurance. Seller
      and AUT shall cause OncoVista to be listed as an “additionally insured” on AUT
      Products Liability Insurance Policy.

    

    Section
      4.08   SEC
      Comments. The
      Seller, at the expense of the Company, shall take all such further acts as
      shall
      be required to resolve the SEC Comments.

    

    Section
      4.09   Additional
      Stock Purchase Agreements. At
      the
      Closing, the payments required to be made to the selling stockholders named
      in
      the Additional Stock Purchase Agreements by the purchasers named therein shall
      be made by the Seller on behalf of the purchasers named therein, which payments
      shall constitute a portion of, and shall be paid from, the Purchase
      Price.

    

    ARTICLE
      V

    

    MISCELLANEOUS

     

    Section
      5.01   Expenses.
      Whether
      or not the transactions contemplated in this Agreement are consummated, all
      costs and expenses incurred in connection with this Agreement and the
      transactions contemplated hereby, will be paid by the party incurring such
      expense or as otherwise agreed to herein.

    

    Section
      5.02   Necessary
      Actions.
      Subject
      to the terms and conditions herein provided, each of the parties hereto agrees
      to use all reasonable efforts to take, or cause to be taken, all action and
      to
      do, or cause to be done, all things necessary, proper or advisable under
      applicable laws and regulations to consummate and make effective the
      transactions contemplated by this Agreement. In the event at any time after
      the
      Closing, any further action is necessary or desirable to carry out the purposes
      of this Agreement, the Seller, the proper executive officers and/or directors
      of
      the Company, or OncoVista, as the case may be, will take all such necessary
      action.

     

    Section
      5.03   Notices.
      Any
      notice or other communication required or permitted to be given hereunder shall
      be in writing and shall be mailed by certified mail, return receipt requested
      
       

      
        
          
          

        

        
          -18-

          
            

          

        

        
          
          
or by the most nearly
          comparable method if mailed from or to a location outside of the United
          States
          or by Federal Express, Express Mail, or similar overnight delivery or courier
          service or delivered (in person or by telecopy, telex, or similar
          telecommunications equipment) against receipt to the party to which it
          is to be
          given at the address of such party set forth in the introductory paragraph
          to
          this Agreement (or to such other address as the party shall have furnished
          in
          writing in accordance with the provisions of this Section 5.03.) Any notice
          shall be addressed to the attention of the Corporate Secretary. A copy
          of any
          and all notices to OncoVista shall be delivered in accordance with this
          section
          to Reitler Brown & Rosenblatt LLC, 800 Third Avenue, 21st
          Floor,
          New York 10022, Attention: Robert Steven Brown, Esq. A copy of any and
          all
          notices to Seller shall be delivered in accordance with this section to
          Torbjorn
          Lundqvist at 1001 ChristyWay,
          Fallbrook, CA 92028 with a copy to Abrams Garfinkel Margolis Bergson LLP,
          4100
          Newport Place, Suite 830, Newport Beach, CA 92660, Attention: Deron M.
          Colby,
          Esq. Any notice or other communication given by certified mail (or by such
          comparable method) shall be deemed given at the time of certification thereof
          (or comparable act), except for a notice changing a party's address which
          will
          be deemed given at the time of receipt thereof. Any notice given by other
          means
          permitted by this Section 5.03 shall be deemed given at the time of receipt
          thereof.

      

    

    

    Section
      5.03   Parties
      in Interest.Except
      as
      expressly provided in Sections 4.01 and 4.05 hereof, this Agreement will inure
      to the benefit of and be binding upon the parties hereto and the respective
      successors and assigns. Nothing in this Agreement is intended to confer,
      expressly or by implication, upon any other person any rights or remedies under
      or by reason of this Agreement.

    

    Section
      5.04    Entire
      Agreement; Modification.
      This
      Agreement sets forth the entire understanding of the parties with respect to
      the
      subject matter hereof (except as provided in Section 5.04), supersedes all
      existing agreements among them concerning such subject matter, and may be
      modified only by a written instrument duly executed by each party hereto.

    

    Section
      5.05   Availability
      of Equitable Remedies.
      Since a
      breach of the provisions of this Agreement could not adequately be compensated
      by money damages, any party shall be entitled, in addition to any other right
      or
      remedy available to it, to an injunction restraining such breach or threatened
      breach and to specific performance of any such provision of this Agreement,
      and
      no bond or other security shall be required in connection therewith, and the
      parties hereby consent to the issuance of such an injunction and to the ordering
      of specific performance.

     

    Section
      5.06   Survival.
      Each of
      the covenants, agreements, representations, and warranties contained in this
      Agreement shall survive the Closing Date until the date 18 months thereafter.
      The statements contained in any document executed by either the Seller or the
      Company relating hereto or delivered to OncoVista in connection with the
      transactions contemplated hereby or thereby, or in any statement, certificate,
      or other instrument delivered by, or on behalf of, either the Seller or the
      Company pursuant hereto or thereto or delivered to OncoVista in connection
      with
      the transactions contemplated hereby or thereby shall be deemed representations
      and warranties, covenants and agreements, or conditions, as the case may be,
      of
      the Seller or the Company, respectively, hereunder for all purposes of this
      Agreement (including all statements, certificates, or other instruments
      delivered pursuant hereto or thereto or delivered in connection with this
      Agreement, or any of the other transactions contemplated hereby). The 
       

      
        
          
          

        

        
          -19-

          
            

          

        

        
          
          
statements contained in any
          document executed by OncoVista relating hereto or delivered to either the
          Seller
          or the Company in connection with the transactions contemplated hereby
          or
          thereby, or in any statement, certificate, or other instrument delivered
          by, or
          on behalf of, OncoVista pursuant hereto or thereto or delivered to either
          the
          Seller or the Company in connection with the transactions contemplated
          hereby or
          thereby shall be deemed representations and warranties, covenants and
          agreements, or conditions, as the case may be, of OncoVista hereunder for
          all
          purposes of this Agreement (including all statements, certificates, or
          other
          instruments delivered pursuant hereto or thereto or delivered in connection
          with
          this Agreement, or any of the other transactions contemplated
          hereby).

      

    

    
       

    

    Section
      5.07   Binding
      Effect.
      The
      provisions of this Agreement shall be binding upon and inure to the benefit
      of
      the Seller, the Company, and OncoVista, and their respective successors and
      assigns; provided, however, that no party hereto shall have the right to assign
      its rights and obligations hereunder without the prior written consent of the
      other parties hereto. 

    

    Section
      5.08    Counterpart.
      This
      Agreement may be executed in one or more counterparts, each of which will be
      deemed an original and all together will constitute one document. The delivery
      by facsimile of an executed counterpart of this Agreement will be deemed to
      be
      an original and will have the full force and effect of an original executed
      copy.

    

    Section
      5.09    Severability.
      The
      provisions of this Agreement will be deemed severable and the invalidity or
      unenforceability of any provision hereof will not affect the validity or
      enforceability of any of the other provisions hereof. If any provisions of
      this
      Agreement, or the application thereof to any person or any circumstance, is
      illegal, invalid or unenforceable, (a) a suitable and equitable provision
      will be substituted therefor in order to carry out, so far as may be valid
      and
      enforceable, the intent and purpose of such invalid or unenforceable provision,
      and (b) the remainder of this Agreement and the application of such
      provision to other persons or circumstances will not be affected by such
      invalidity or unenforceability, nor will such invalidity or unenforceability
      affect the validity or enforceability of such provision, or the application
      thereof, in any other jurisdiction.

    

    Section
      5.10  Headings.
      The
      Article and Section headings are provided herein for convenience of reference
      only and do not constitute a part of this Agreement and will not be deemed
      to
      limit or otherwise affect any of the provisions hereof.

    

    Section
      5.11  
      Governing
      Law.
      This
      Agreement will be deemed to be made in and in all respects will be interpreted,
      construed and governed by and in accordance with the law of the State
      of New York, without regard to the conflict of law principles thereof.

    

    [REMAINDER
      OF PAGE INTENTIONALLY BLANK]

     

    
      
        
        

      

      
        -20-

        
          

        

      

      
        
        

      

    

     

    IN
      WITNESS WHEREOF, the
      parties hereto have executed and delivered this Agreement in a manner legally
      binding upon them as of the date first above written.

     

    
      	 	 	 
	 	ONCOVISTA,
              INC.
	 
 	 
 	 
 
	 	By:  	/s/ Alexander
              Weis
	 	 	
              
Name:
              Alexander L. Weis, Ph.D.
	 	 	
              Title:
                Chairman of the Board of Directors, 
                Chief
                  Executive Officer, and 

                President

              

            
	 	 	 
	 	
            	 
	 	
              /s/
                Torbjorn Lundqvist

              
                
Torbjorn
                B. Lundqvist

            
	 	 

    

    
       

      
        	 	 	 
	 	
                AVIATION
                  UPGRADE TECHNOLOGIES, INC.
                  

              
	 
 	 
 	 
 
	 	By:  	/s/ Torbjorn
                Lundqvist
	 	
                
Name:
                Torbjorn B. Lundqvist
	 	
                
                  
                    Title:
                      Chairman of the Board of Directors,

                    Chief
                      Executive Officer, and 

                    President

                  

                

              

      

    

     

    
      
        
        

      

      
        -21-

        
          

        

      

      
        
        

      

    

     

    List
      of Schedules and Exhibits

     

    
      
        	
                Schedule
                  3.01(a)(i)

              	
                SEC
                  Comment Letters

              
	
                Schedule
                  3.01(c)

              	
                Disclosure
                  Re: Parent CA Qualification and Subsidiary Nevada Qualification

              
	
                Schedule
                  3.01(f) 

              	
                Options,
                  Warrants, and Convertible and Exchangeable Securities

              
	
                Schedule
                  3.01(i)

              	
                Schedule
                  of Additional Stock Purchase Agreements and the Selling Stockholders
                  Named
                  therein

              
	
                Schedule
                  3.01(j)

              	
                List
                  of Current Non-Affiliate Liabilities

              
	
                Schedule
                  3.01(k)

              	
                Insurance
                  Policies

              
	 	 
	
                Exhibit
                  2.02(a)(iii)

              	
                Company
                  Officers’ Certificate

              
	
                Exhibit
                  2.02(a)(iv)

              	
                Seller’s
                  Certificate

              
	
                Exhibit
                  2.02(a)(v)

              	
                OncoVista
                  Officers’ Certificate

              
	
                Exhibit
                  2.02(a)(vi)

              	
                Cross-Receipt

              
	
                Exhibit
                  3.02(e)

              	
                OncoVista
                  Private Placement Memorandum dated July
                  25, 2007, as amended and Supplemented by Supplement No., dated
                  July
                  30,
                  2007

              

      

    

     

    
      
        
        

      

      
        -22-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]